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editorial
The future of medicine: 
A medical student’s 
perspective
As medical students, we spend much of our education busily 
learning vast amounts of information in order to gain the 
knowledge we require to become competent clinicians.  Much 
of the first two years of medical school is spent in didactic 
teaching.  In the third and fourth years of our education we 
rush around the hospital during our clinical clerkship years 
attempting to apply that knowledge and to learn our craft from 
our mentors and supervisors.  We are immersed in the here 
and the now and passing the next looming exam!  
Even though we are the future leaders in healthcare, we are 
rarely asked what we think the future of medicine holds.  
This is a shame, since in my experience as a student at the 
Schulich School of Medicine and Dentistry I have found that 
my classmates have many ideas and great vision as to the future 
of the practice of medicine.  We are also in a unique position 
of still maintaining our sense of idealism as we have not been 
working on the frontlines for very long.  We can see where 
change can occur since our experiences in the wards and 
clinics are fresh and new.  Having never come across resistance 
and barriers to change, we can imagine the possibilities that 
the future can hold.  It is for this very reason that in this issue 
of the UWOMJ we have decided to explore what medical 
students believe the future holds for medicine.  I hope that you 
enjoy reading these pages and take the opportunity to dream 
and to envision what you hope will be the future of medicine 
and embolden yourself to make change happen.    
My own personal vision of the future of medicine is biased by 
my previous experience as a research scientist.  I believe that 
the merging of the fields of molecular biology, biochemistry, 
materials science, engineering and nanotechnology will occur 
in the very near future and will lead to medical breakthroughs 
and treatments that are only now emerging from the realms of 
our imagination.  We are entering an age that is full of promise 
and will reveal the mechanisms of numerous human diseases.  
These advances will lead to new treatment options for patients. 
The age of personalized medicine is just beginning and it is 
going to change the way we practice medicine.  
The sequencing of the human genome and the development of 
bioinformatics tools to manage and analyze the sequence of our 
DNA have provided a glimpse into the complexity of our genetic 
makeup.  The concomitant adaptation of mass spectrometry to 
the analysis of proteins now allows us to identify the protein 
makeup of a cell.  These technological breakthroughs will be 
joined by the newly emerging field of metabolomics that will 
allow us to identify a large number of metabolites found in 
the human body.  Armed with this new information detailing 
cellular processes during times of health and disease, the 
methods we use to manage patients and develop therapeutic 
drug targets will change at a rapid pace.  Breakthroughs in the 
fields of materials science, engineering and nanotechnology will 
allow for the miniaturization of these applications so that they 
can be deployed for routine clinical use.    
Imagine detecting life threatening genetic conditions and long 
term genetic susceptibilities at birth.  A patient will have a 
lifestyle plan charted out to prevent the development of diseases 
detected in their genetic profile.  Over the course of a person’s 
lifetime the protein and metabolic profiles of their cells will be 
monitored to determine the onset of pathological changes.  This 
testing will allow physicians to begin treating conditions before 
they have detectable clinical signs and symptoms, thus altering 
the course of a disease from the very beginning.  A patient’s 
genomic, proteomic and metabolomic information will also be 
used to select the most ideal, individualized pharmacotherapies. 
We are approaching an exciting era full of enormous change.  
Today’s physicians will need to develop public policy and lobby 
for the best delivery of future technologies.  And both today’s 
physician and tomorrow’s physician will need to decide which 
technologies we adapt, always keeping humanity’s best interests 
in mind as we progress towards an exciting tomorrow.  Turn 
the page to see what other medical students at Schulich feel the 
future holds! 
Melissa J MacPherson, PhD (Meds 2014)
Senior Associate Editor
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abstract
The paradigm of medical resident duty hours is currently un-
dergoing vast changes, as research has demonstrated the neg-
ative effects of sleep deprivation on the wellbeing of both pa-
tients and residents alike. These changes began in the United 
States, where reduced work hour schedules for residents have 
been implemented within the past decade. However, the effec-
tiveness of these changes has been debated in the literature. In 
Canada, this issue has only recently come into spotlight. Under 
the guidance of the Royal College of Physicians and Surgeons 
of Canada, a task force was assembled in 2012 with two main 
objectives: gather all evidence related to resident duty hours, 
fatigue, and patient safety, and to create a national Canadian 
consensus on resident duty hours.
In 1984, New York City was the setting of a new wave of think-
ing about residency training programs within the medical profession. 
That year, the death of Libby Zion, a lawyer’s daughter, initiated the 
Zion vs. New York Hospital case, which would have an indirect im-
pact on international rules for resident work hours.
Traditionally, it was not uncommon for residents to work up to 
36 consecutive hours with minimal sleep, accumulating well over 100 
hours of work in a week. Some considered this a rite of passage into 
the medical profession, while others saw it as a valuable learning tool. 
When the death of teenager Libby Zion was traced down to a medical 
error, more attention was drawn to the effect of sleep deprivation on 
residents’ performance on the wards.
What effect does sleep deprivation have on residents? One re-
view found that with acute sleep deprivation, residents showed 
decreased performance on tasks that required prolonged, vigilant 
concentration, but were resilient in performing brief, psychomotor 
tasks requiring manual dexterity and short-term recall.1 Further-
more, resident mood was affected, with increased anger, hostility, 
and symptoms of depression being noted – all factors that hinder the 
physician-patient relationship. In addition, one study found that ex-
tended shifts put residents’ safety at risk, by increasing the likelihood 
of reporting a motor vehicle accident after a call shift.2
A landmark study published in the New England Journal of 
Medicine compared two different work schedules head-to-head.3 
The first schedule, considered “traditional,” had an average of 77-81 
work hours per week with up to 34 hours of continuous work and 
1 in 3 overnight call. The second, or “interventional” schedule, had 
60-63 work hours per week maximum, 16 hours of continuous work 
maximum, and a day-call versus night-call designation, rather than a 
whole day of call. These schedules were randomized among internal 
medicine residents, and patient safety measures were prospective-
ly followed. When researchers compared the traditional schedule 
and interventional schedule respectively, they found that residents 
made 35.9% more serious medical errors (136.0 vs. 100.1 per 1000 pa-
tient-days), 22.0% more total medical errors (193.2 vs. 158.4 per 1000 
patient-days), 20.8% more serious medication errors (99.7 vs. 82.5 per 
1000 patient-days), and 96.5% more serious diagnostic errors (21.6 
vs. 11.0 per 1000 patient-days), while on the traditional schedule.3 
In light of these findings, in 2003 the Accreditation Council for 
Graduate Medical Education (ACGME) in the United States institut-
ed limits on resident work hours: 16 hours maximum for continuous 
shifts for PGY-1 (more hours allowed for seniors), 80 hours maximum 
per week, and 1 day off per week averaged over a 4-week period.4 
Any residency program’s accreditation is endangered if their work 
protocols are not congruent with the ACGME. Unfortunately, data 
collected after these changes have shown mixed results as to the ef-
fectiveness of reduced hours. A systematic review of 7 studies (one of 
which was conducted after the 2003 ACGME changes) comparing 
reduced hour schedules with traditional schedules looked at mortal-
ity, adverse events, and medication errors as outcomes.5 The results 
showed that some outcomes improved, others declined, and still 
others showed no change. For example, mortality was largely unaf-
fected by reduced hours, but medication errors were reduced.5 The 
authors emphasized a distinction between mortality outcomes, and 
task-based outcomes, the latter of which may be more susceptible to 
sleep deprivation. Although there were limitations within the studies 
in this review, such as the failure to measure baseline characteristics, 
the point is raised that reduced-hour schedules may not have the ef-
fects that were once anticipated.
There may be negative consequences with reduced hour work 
schedules. Proponents of the traditional, long hour work schedules 
raise the argument that by reducing hours and increasing patient 
hand-over, an element of discontinuity is introduced which in itself 
may increase medical errors. In addition, fewer predictable hours 
may not prepare residents for independent practice, where hours are 
not limited and may be unpredictable. This may be reflected by an 
increase in the length of residency programs to allow for adequate 
clinical exposure. A survey of surgical residents in the United States 
found that many are unsatisfied with the reduced work-hour chang-
es: 55.1% believed their education declined, and 68.4% felt they were 
not being prepared for senior roles.6 Although 61.9% of junior surgi-
cal residents had an increase in their quality of life, 54.4% of senior 
residents found a decline in their quality of life, likely due to seniors 
adopting the work that the juniors could not complete on their re-
duced hour schedules. Shockingly, 67.6% of surgical residents report-
ed non-compliance with the work-hour limits, and 62.1% reported 
falsifying duty hours.6 
In Canada, the resident association of each province has the 
daunting task of negotiating collective agreements for medical res-
Tides of change 
The future of Canadian medical resident work hours
Jouseph Barkho (Meds 2015)
Faculty Reviewer:  Dr. Catherine Yanchula, MD, CCFP, FCFP (Department of Family Medicine) 
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idents. Presently, Quebec has been the only province to introduce 
drastic changes to their collective agreement regarding work hours. 
In 2007, the collective agreement of the Fédération des médecins rés-
idents du Québec, which at the time permitted 24-hours of consec-
utive work, was challenged under the grounds that it violated both 
the Canadian Charter of Rights and Freedoms and the Quebec Char-
ter of Human Rights and Freedoms.7 Four years later, in 2011, a new 
collective agreement was signed, stating that residents will work no 
more than 16 consecutive hours. The total weekly hours will remain 
approximately the same—the hours will simply be re-distributed.7 
Where is the rest of Canada heading in terms of resident work 
hours? In 2012, the Royal College of Physicians and Surgeons of Can-
ada launched a project titled, “Towards a Pan-Canadian Consensus 
on Resident Duty Hours.”8 By creating a National Steering Com-
mittee on Resident Duty Hours (NSC) consisting of multiple stake-
holders involved in resident training, and taking an evidence-based 
approach, the Royal College hopes to develop national Canadian rec-
ommendations on resident duty hours. The goals of the project are 
to (1) compile all current evidence on this topic, and (2) facilitate, “…
educators, governments, policy makers, patient safety experts, and 
others, to come to a single, pan-Canadian statement on resident duty 
hours issues, directions, and best practices.”8
In June of 2013, the NSC released the final results of their project. 
Firstly, the NSC does not support reducing the total number of work 
hours, but rather re-distributing the hours such that long stretches 
of consecutive hours are minimized.8 Secondly, the original rationale 
behind reduced hours was the notion that resident fatigue impacts 
patient outcomes.  However, evidence collected by the NSC has been 
inconclusive as to whether reduced duty hours improves patient out-
comes. Why is this the case? The relationship between resident fatigue, 
medical errors, and patient safety is not as clear as once anticipated.8 
Fatigue does not affect each resident the same way, nor is sleep-depri-
vation the only factor that influences fatigue.8 Although the NSC does 
acknowledge that current schedules pose risks to the, “physical, men-
tal, and occupational health of residents,” they emphasize that we must 
not place the spotlight entirely on duty hours, but rather take a com-
prehensive, holistic approach by addressing factors beyond duty hours 
alone.8 Additional factors to be considered include resident education, 
health service delivery, and resident supervision.8
The NSC also acknowledges significant variation between resi-
dency programs, and that reduced consecutive hours may affect each 
specialty program differently.8 Changes must be tailored specifical-
ly for each type of residency, rather than making uniform changes 
across all different residency programs. 
The NSC has provided five key recommendations for Canadian 
residency programs, in accordance with their findings:8
1. We need a comprehensive approach to minimize fa-
tigue-related risk, including “fatigue-risk management 
plans” in all residency programs across Canada.
2. Resident education needs to be re-modeled, along with 
resident duty hours, to ensure adequate medical training 
and exposure for residents.
3. Residency programs need to be held accountable for main-
taining these changes through accreditation processes.
4. Multiple models of work schedules for after-hours care 
should be created and evaluated as to their impact on 
patient care.
5. An independent, pan-Canadian council, whose sole pur-
pose is to evaluate resident duty hours, should be created.
These changes appear promising to both patients and residents 
in Canada, however the NSC was not specific as to the timeline for 
residency programs to adopt these changes. It may be some time 
before new schedules are formulated and adopted across Canadian 
residency programs.
Picture the following scenarios: a well-rested resident caring for 
patients mainly through reports, or a fatigued resident providing di-
rect patient care through their own history and physical examination. 
Who provides the best patient care? Working long consecutive hours 
has disadvantages for both the patient and resident alike, however, 
reducing duty hours also has its own disadvantages. It is important to 
study the disadvantages of reduced consecutive-hour schedules, so 
that they may be minimized or eliminated during the policy-making 
process. Canada has taken the first step towards addressing this issue 
by compiling a task force whose aim was to create an evidence-based, 
pan-Canadian guideline regarding resident duty hours. With the 
NSC’s final report, Canada is headed towards changes which will 
ultimately improve the health-care of Canadian citizens and simul-
taneously maximize the health and education of medical residents.
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Towards Healthier Doctors
Kevin J Dueck (Meds 2016)
Faculty Reviewer:  Dr. Robert R Hammond, MD, FRCPC (Department of Pathology) 
On June 17, 1963, Canadian Health Minister Judy LaMarch an-
nounced that cigarettes were linked to lung cancer. It was an im-
portant announcement for human health and one for which Canada 
displayed leadership. Unfortunately, after the news conference she 
promptly lit a cigarette. Sneering at the seeming hypocrisy of such 
an act would be easy, but we shouldn’t throw stones. Do we not rec-
ommend lifestyle and behavioral changes targeting patient wellness 
while ignoring them in our own lives? This gap between physician 
recommendations and actions needs to be closed. Not only for the 
good of physicians, but that of our patients and the healthcare system.
wellness concerns
Wellness is multidimensional. It involves more than a lack of 
illness as traditionally thought. The definition of health according 
to the World Health Organization is, “a state of complete physical, 
mental and social well-being and not merely the absence of disease 
or infirmity.” This definition encompasses a broader sense than mere 
biological function. Wellness includes the dimensions of spiritual, 
occupational, environmental, emotional and intellectual wellbeing 
along with personal awareness and proactivity in one’s health. 
The training and practice of medicine are difficult. Maintain-
ing the dimensions of wellness is not easy in these environments. 
One’s personal wellbeing and ability to care for patients can suffer. 
A physician’s wellness is important and an unmatched healthcare 
commodity.
Trainees are faced with many stresses, from their changing 
roles and increased workload to life events. Trainees are embedded 
in a high-stress environment and have high rates of depression.1,2  
Approximately a quarter of medial students experience depression, 
but are less likely to seek help – significant barriers such as stig-
ma and confidentiality exist.3,4 Studies suggest that mental health 
worsens through medical school and this distress can continue 
through postgraduate training.5,6 According to a multi-institutional 
study in the United States, 11% of medical students seriously con-
sidered dropping out in the preceding year, with burnout, depres-
sion and quality of life being predictive factors.7 Although the above 
studies focused on mental health, other aspects of wellness deserve 
similar concern.
Physician wellness also impacts the quality of care delivered. 
Burnout has been linked to reduced professionalism and empathy,8 
whereas wellbeing is associated with compassion for patients.9 
Physicians proactive about their health more often discuss health 
promotion with their patients,10 and yet a third of physicians do not 
seek regular healthcare.11 Interaction with other healthcare team 
members is likely negatively impacted when personal wellness is 
neglected, expanding the effect of this neglect. These concerns 
have led to a number of undertakings targeting physician and train-
ee wellness.
wellness efforts
There is reason to be optimistic. Efforts are underway to pro-
mote wellness throughout the medical profession. These include 
national, provincial and institutional initiatives: large-scale efforts 
to provide resources and revise training requirements, and smaller 
projects addressing student wellness. The essential nature of physi-
cian wellness is gaining traction.
Large-scale efforts target both trainees and physicians (links 
below). These provide resources specific to issues of the medical 
profession including crisis lines. At the national level the Canadi-
an Medical Association (CMA) has established the Center for Phy-
sician Wellbeing and recently launched the Canadian Physician 
Health Institute (CPHI) in partnership with the Canadian Medi-
cal Foundation to support physicians and trainees. At the resident 
level the Canadian Association of Interns and Residents (CAIR) 
provides resident specific resources on their website and supports 
the recently launched ePhysicianHealth website. The latter re-
source provides online modules addressing specific wellness topics. 
Changes are also afoot in residency and clerkship call hours, lim-
iting demands on trainee time. The Canadian Federation of Medi-
cal Students (CFMS) recently launched a medical student wellness 
website and is distributing wellness packages to all Canadian med-
ical students.  In Ontario the Ontario Medical Association’s (OMA) 
Physician Health Program (PHP) and the recent inaugural Ontario 
Medical Student’s Association Wellness retreat highlight further 
encouraging efforts. Thankfully, this is a time of increasing activity 
in this area with many complimentary efforts being launched. 
Small-scale efforts involve multiple approaches. Curriculum 
changes have been introduced to reduce competition between 
students with broad pass-fail grading along with optimizing exam 
schedules as occurred at the University of Ottawa. In order to make 
personal connections with students both peer and faculty mentor-
ship programs have not only become commonplace but standards 
for accreditation. Some schools have created separate support ser-
vices for medical students and integrated wellness into their cur-
riculum such as Queen’s University. A number of student led initia-
tives have also been funded, giving the student perspective a larger 
role and allowing targeted activities addressing student needs.  
Thus, wellness is being approached at both the large- and 
small-scale, within and across medical training and practice.  While 
coordination of efforts is important, the wisdom of this approach 
whether intentional or otherwise is that wellness is clearly not 
‘one-size-fits-all’. Although the breadth of efforts demonstrates 
that the issue of wellness has earned wider attention, there is much 
work to be done. At the professional and resident level positive 
changes are underway, however, a key time to engage learners is 
during their undergraduate medical education.  In the words of Dr. 
Chris Simpson, CMA President-elect 2013-2014, “Given that health 
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and wellness habits are learned early, it is this population of med-
ical colleagues who, arguably, would benefit the most from a more 
activist wellness program.”12 
forging healthier doctors
Focusing on the student level is an important way forward for 
wellness in the medical profession. By nurturing wellness at the 
early stages of training students can learn skills and be imparted 
values that can lead to changes in the larger healthcare culture as 
their careers progress. Coordination of the current efforts is needed 
to best address student wellness. A number of improvements are 
possible to current programs.
Firstly, initiatives should be carefully planned and monitored. 
Thus far evidence of effectiveness has been lacking.  This concern 
must be addressed in the planning of new projects and implement-
ed in existing ones; ensuring efforts are not futile or counterproduc-
tive. Though driven by positive intentions, one must have evidence 
to support the interventions proposed.5,9 Programs for mentoring 
in the majority lack short and long-term evaluation criteria, making 
assessment of the effectiveness difficult.13 Thus, existing programs 
need to clarify their goals and put in place clear outcome measures.
Secondly, implementation must be based on the best avail-
able evidence.  Using stigma as an example, the importance of evi-
dence-based interventions is apparent. Stigma is a major concern, 
especially towards mental health.  This leads students to feel unable 
to seek help and ostracized due to their illness.  Addressing stigma 
is a significant component of moving forward with wellness, but 
how does one approach this?  National awareness campaigns do not 
appear to be effective alone,14 while contact based workshops do 
impact the stigma of those attending.14-16 However, the delivery of 
these workshops is key to their effect as they can also consolidate 
negative views.17 Learning how to deliver programs in accordance 
with best evidence is a key aspect of moving forward. 
Lastly, some efforts must be targeted to specific issues and 
utilize models of behavioral change.  As noted above, large aware-
ness campaigns are not globally effective.  Specific issues need to 
be targeted and skills taught, whether these be life skills, person-
al coping skills or healthy behaviors. Furthermore, the delivery 
should be planned using a validated model of change. By example, 
the I-Change model involves 3 stages, those of awareness, motiva-
tion and action; all must be considered in bringing about positive 
change.18,19
Trying to introduce such changes will not happen without 
stressing the importance of wellness in the curriculum and the pro-
fession. It must be seen as part of professional responsibility; first 
to yourself, second to your peers and profession and finally to your 
patients. Making wellness central to medical education will not be 
without issue. A proportion of the student population is resistant to 
the idea of needing help or having future difficulties. The topic of 
wellness is thus difficult to broach with them. Furthermore, there 
still exists significant stigma especially towards mental health in 
our society. These need to be overcome for the good of all. Change is 
needed and must be evidence based, thoroughly planned and care-
fully implemented.
conclusion
Wellness is a goal of medicine and needs to be applied to the 
training and practice of those involved as well. It is a part of aligning 
our practice with our principles. It is about the validity of our ad-
vice for our patients, but also the care we provide ourselves. While 
systemic and student barriers exist, there are efforts underway to 
address the shortcomings. Addressing wellness needs at the train-
ee level is an approach that will seed long term change within the 
culture of physicians, wellness becoming central to the curriculum 
and penetrating the healthcare system. If successful, these students 
become more resilient doctors, better teammates and better care-
givers. The move towards physician wellness is needed to form a 
connected, caring network of peers working together for their own 
and their patients’ wellbeing. 
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Robotic Surgery
How are we training future operators?
Alex Jiang (Meds 2015)
Faculty Reviewer:  Dr. Christopher Schlachta, MD, FRCSC (Department of Surgery)
background
Since 1921 when Czech playwright Karel Capek introduced the 
notion of and coined the term “robot” in his play Rossom’s Universal 
Robots, robots have taken on increasing importance in society in sec-
tors from industry to military and now, medicine.1 First introduced in 
2000 by Binder and Kramer, robotic surgery has revolutionized the 
field of minimally invasive surgery and has been rapidly adopted for 
various procedures.2 Perhaps the most renowned surgical robot now-
adays is the da Vinci Surgical System (dVSS) (Intuitive Surgical, Inc.).
Urologists, cardiac surgeons and general surgeons have swiftly 
adopted this technology and have been instrumental in its growth. 
Today, robotic-assisted laparoscopic radical prostatectomy (RAL-
RP) is the most commonly performed robotic procedure world-
wide. In 2002, only 766 RALRPs were performed in the United 
States. By 2007, this number had swelled to 48 000, and represented 
68% of all radical prostatectomies.3,4 Other urological procedures 
performed with robotic assistance include pyeloplasty, nephrec-
tomy, radical cystectomy and urinary diversion.4 Cardiac surgeons 
further refined this technology. Mohr et al used dVSS to perform 
CABG on 131 patients and mitral valve repair on 17 patients, and 
discovered that robotic systems could be used safely in select pa-
tients to perform endoscopic cardiac surgery.5 Gynecology and gen-
eral surgery have also adopted this system for certain procedures 
including hysterectomy, myomectomy, sacro-colpopexy, Roux-en-Y 
gastric bypass and Nissen fundoplication.3 
Despite the growing popularity of this technology, education 
of residents and fellows has not kept pace with this new era of sur-
gery. Duchene et al conducted a survey of urology residents training 
in laparoscopic and robotic surgery. They determined that robotic 
procedures were being performed at 54% of respondent hospitals 
and residents were involved in the majority of these cases, but only 
38% of residents considered their expertise satisfactory.6 A more 
recent survey of obstetrics and gynecology residents showed that 
79% of them felt robotics training should be included in their res-
idency program and 69% felt that their training was inadequate.7 
The Dutch Healthcare Inspectorate has also published a report 
stating that 50% of the hospital lacked a standardized method for 
assessing surgeons’ competence before allowing them to operate 
with robotics.8 In an attempt to address these shortcomings, this 
article highlights the challenges of establishing a robotics training 
program and the need for a standardized training curriculum.
robotic surgical system
The Figure depicts the four components of dVSS, which con-
sists of surgeon console, patient-side cart, EndoWrist instruments, 
and vision system. The console allows the surgeon to manipulate 
the robotic arms. The patient-side cart is where the patient and ro-
botic arms are positioned. EndoWrist instruments are a set of spe-
cialized tools that allows for clamping, suturing and tissue manipu-
lation. The vision system provides the entire OR team with the live 
feed of the operating field.9
The surgeons see a 3-D image of the surgical field through an 
integrated stereoscopic viewer attached to the console. The image 
shows the intraoperative area and the surgical instruments at the 
ends of the robotic arms. The surgeon controls the arms with a joy-
stick and pedals. The movement of the surgeon’s hands are trans-
mitted electronically and reproduced by the robotic arms. These 
arms have joints that allow free movement comparable to that of 
human arms and hands. They also filter physiologic tremors, which 
allows for more stable arm motions. Since the robotic arms mim-
ic the movements of the surgeon, the experience, proficiency and 
judgment of the surgeon influence the surgical results.10 Nonethe-
less, when operated by a skilled user, it can yield tremendous bene-
fits. The Table highlights its notable advantages and disadvantages.
advantages disadvantages
Minimally invasive Long set-up time
Fewer complications Limited console time for training 
Better postoperative quality-of-life No tactile feedback
Shorter recovery period Expensive capital and running costs 
3-D visualization Long and steep learning curve 
Tele-surgery Trainer cannot teach trainees using 
the system 




Table. Advantages and disadvantages of robotic surgery.1
Figure. The da Vinci Surgical System. From left to right: surgeon console, vision 
system, patient-side cart and EndoWrist instruments.9 
Image ©[2013] Intuitive Surgical, Inc.
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challenges
The cost of robotic surgery can be a huge impediment to estab-
lishing a robotics surgery program. This cost includes that of the 
robot, annual maintenance, disposable surgical instruments, operat-
ing room time, medication, hospitalization and health professionals. 
With a purchase price of $1.2 million and an annual maintenance 
fee of $100 000, the dVSS poses a significant financial challenge for 
many hospitals. Furthermore, Steinberg et al estimate that it would 
cost an additional $217 000 to train a single resident to proficiency.12 
More problematic is the steep learning curve associated with 
the dVSS. Menon et al reported an initial operation time of 360 min 
for RALRP.11 Similarly, it has been demonstrated that an average 
of 74 cases are required to achieve competency.12 Heightened ex-
pectations from patients and medico-legal implications, as well as 
demands from hospital administrators to maximize results, mean 
that there is a limited opportunity for residents to train with the 
system.13 Even more significant is the lack of any standardized com-
petence-based training curriculum, which has been consistently un-
derlined in successive literature.14,15
the new training curriculum
Guzzo et al and Shah et al proposed three essential phases in 
a structured robotics training program: preclinical phase, bedside 
assistant phase and operative console phase. During the preclini-
cal phase, trainees receive information training delivered through 
didactics, videos and live surgeries. They also receive hands-on ex-
perience through inanimate teaching modules, cadaver dissection 
and animal laboratories. In the bedside assistant phase, the trainees 
function as co-surgeons, learning more advanced skills such as tro-
char and robot placement, instrumentation and troubleshooting. In 
the console phase, the trainees begin performing parts of the robotic 
procedures. They will be introduced to cases of increasing difficulty 
and evaluated objectively along the way. Live feedback will be pro-
vided to facilitate immediate skill enhancement.16,17
Simulation technology has been developed to address problems 
relating to cost and exposure time. Several virtual reality (VR) sim-
ulators for dVSS have been marketed. These include ProMIS (CAE 
Healthcare), SEP-Robot (SimSurgery AS) and dV-Trainer (Mimic 
Technologies).18 Each of these simulators is comprised of a master 
console with finger cuff telemanipulators and a binocular 3-D visual 
output. Simulation exercises include EndoWrist manipulation, cam-
eral control, object transfer, needle targeting, etc. The VR simulators 
allow for deliberate practice in a safe and controlled environment. 
Additionally, they allow for real-time assessment of trainee skill.8 
A systematic review demonstrated that VR simulators are effective 
training tools for junior trainees and can be used as adjuncts to tra-
ditional training methods.4 Multiple studies have also demonstrated 
face, content and construct validity for this hardware.18
The concept of mastery learning has also garnered consider-
able attention in recent years for simulation-based training. Mas-
tery learning is an extreme form of competency-based education 
and requires learners to acquire the clinical knowledge and skill to 
a degree measured against fixed proficiency standards.19 In mastery 
learning, the educational results are uniform with varying educa-
tional time. This is in contrast to the current educational paradigm 
where students are given limited hours of lecture or practice time 
and assessed at the end, resulting in varying performance. The effi-
cacy of this approach has been demonstrated for simulation-based 
central venous catheter insertion and advanced cardiac life support 
trainings.20,21 Residents trained with a mastery learning approach 
improved their skills compared to those trained with more tradi-
tional methods. It is possible to integrate this training paradigm with 
da Vinci simulators to address shortfalls in robotic surgery training 
and establish a competency-based training curriculum. 
conclusion
With the rapid proliferation of robotic surgery in various spe-
cialties, there needs to be a standardized competence-based train-
ing curriculum for trainees. While there are foreseeable challenges, 
technologies and training paradigms are also evolving concurrently. 
With increasing quality of VR simulators and growing evidence sup-
porting mastery learning, applications of robotic surgery will surely 
expand in the next decade and beyond.
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The use of ultrasound guidance in 
lumbar neuraxial blockade
Hao Li (Meds 2016)
Faculty Reviewer: Dr Sugantha Ganapathy, MBBS  
(Department of Anesthesiology and Perioperative Medicine) 
Neuraxial blockade of the lumbar spine is the standard of care 
for obstetric procedures (eg. Cesarean section) and orthopedic op-
erations of the lower extremities when general anesthesia is contra-
indicated or unnecessary.1 A local anaesthetic is injected epidurally 
(in epidural anaesthesia) or intrathecally (in spinal anaesthesia) at 
a level of the lumbar spine that is presumed to be below the conus 
medullaris, in order to minimize the risk of accidental trauma to 
the spinal cord.2 Generally, this corresponds to the L3-4 vertebral 
interspace. 
The current technique for locating the L3-4 interspace is by 
palpation of external anatomic landmarks. It is approximated by 
the height of Tuffier’s line, an imaginary line connecting the highest 
points of the two iliac crests. This level is estimated to be either the 
L3-4 interspace or the L4 spinous process. The needle is inserted at 
this level at the center of the spine. Insertion into the epidural space 
is confirmed by loss of resistance to an injection of saline or air, and 
insertion into the intrathecal space is confirmed by the return of 
cerebrospinal fluid through the needle.
Unfortunately, evidence suggests that the technique of locat-
ing interspace levels by external palpation presents serious safety 
issues. As demonstrated by Broadbent et al.2 in an observational 
study comparing external palpation to magnetic resonance imaging 
(MRI), identification of interspace using external palpation could 
be quite inaccurate. In fact, levels were identified correctly only 
29% of the time, and this inaccuracy was especially pronounced in 
obese patients. In most of the errors, the physician underestimated 
the interspace level. This meant that the level they actually identi-
fied was higher than the level that they thought was identified (eg. 
believed that the level was L3, when it was actually L2), which can 
potentially lead to unintentional puncture of the spinal cord during 
injection.
This substantial risk of underestimating vertebral levels has 
indeed resulted in accidental spinal punctures in the clinical set-
ting. Moen et al.3 conducted a review of neurological complications 
associated with lumbar neuraxial blockade in Sweden from 1990 to 
1999, and found that nine patients suffered from traumatic spinal 
cord lesions following the procedure. In eight of these cases, the 
physician thought that the puncture was performed at a safe inter-
space level, exemplifying an underestimation of level. The sequel-
ae for five of these patients was severe pain, and for the remaining 
three, cauda equina syndrome. Hamandi et al.4 reported five cases 
in the United Kingdom of irreversible neurological impairment re-
sulting from puncture of the spinal cord during lumbar neuraxial 
blockade. In all of the cases, the physician underestimated the level 
of interspace punctured. 
The incidence of spinal cord trauma associated with lumbar 
neuraxial blockade, most of which caused by underestimation of 
spinal level, is not high (1 in 190000, based on studies so far) as the 
majority of incorrect punctures are benign.3 However, when it does 
occur, the consequences that follow such a complication can be 
devastating for both the patient and his/her family. Over the last 
decade, more and more physicians are beginning to perform their 
lumbar neuraxial blockade procedures under ultrasound guidance. 
Evidence suggests that ultrasound guidance, which is currently the 
only modality of guidance for these procedures other than palpa-
tion, makes lumbar neuraxial blockades more accurate and poten-
tially safer. A detailed procedural description of ultrasound-guided 
lumbar neuraxial blockade can be found in a review by Chin et al.5
Current research shows that identification of vertebral lev-
els using ultrasound guidance carries much more accuracy than 
through external palpation. In an observational study by Watson et 
al.6 of patients undergoing spine MRI, ultrasound-guided identifi-
cation of the L3-4 interspace was accurate 76% of the time. Furness 
et al.7 compared palpation-guided to ultrasound-guided identifi-
cation of lumbar interspaces in patients scheduled for spine X-ray, 
and found that the ultrasound-guided method carried an accuracy 
of 70%-90%, while the palpation-guided method was only 30%-
40% accurate.
Clinically, performing lumbar neuraxial blockade under ul-
trasound guidance appears to generate more favourable patient 
outcomes than the conventional method. Grau et al.1,8 conducted 
several randomized clinical trials comparing palpation-guided vs. 
ultrasound-guided lumbar neuraxial blockade with respect to both 
technical and patient outcomes. In one study performed on parturi-
ents undergoing conventional delivery or Cesarean section,8 it was 
found that the ultrasound-guided method involved fewer puncture 
attempts than the palpation-guided method. A puncture attempt 
was defined as any puncture from outside the body, or any protrac-
tion and redirection of the needle within the body. Thus, this study 
showed that an ultrasound-guided procedure required less needle 
manipulations due to accidental misplacement, therefore holding 
the potential to minimize the risk of unintentional injury to the 
patient. Interestingly, patients in the ultrasound group also experi-
enced better analgesia compared to those in the control group. This 
may be attributed to a greater accuracy in injection, such that the 
drug distributes itself equally on both sides of the injection site. Pa-
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tients in the ultrasound group suffered from fewer side effects and 
overall, were significantly more satisfied than the control. Another 
study by Grau et al.1 concerned combined spinal-epidural anaesthe-
sia performed on parturients scheduled for Cesarean section. Again, 
the ultrasound-guided method involved fewer puncture attempts 
than the palpation-guided method, and patients in the ultrasound 
group reported greater satisfaction. While these data pertain solely 
to obstetrical patients, it does not seem unreasonable to extend the 
results to orthopedic patients as well.
In light of the severe and irreversible neurological complica-
tions that can occur with spinal cord trauma due to the inaccura-
cy of needle placement in conventional palpation-guided lumbar 
neuraxial blockade, and the findings that ultrasound-guided lum-
bar neuraxial blockade is more accurate and leads to greater patient 
satisfaction, it is likely that the ultrasound-guided method will re-
place the current protocol as the standard of care in the future. 
With regards to challenges, an obvious concern with ultra-
sound-guided lumbar neuraxial blockade is potential cost. Another 
obstacle is patient safety. While ultrasound scanning itself is gen-
erally regarded as safe, it is possible for the transmission gel to leak 
into the puncture site.5 The safety implications of this are current-
ly unclear and require careful observation. Finally, it is recognized 
that the real-time ultrasound-guided procedure is fairly difficult, 
requiring stabilization of the ultrasound probe on the patient’s back 
and dexterity with needle angle changes. Furthermore, the popula-
tion in whom the conventional technique poses difficulties, such as 
the morbidly obese, may also have poorly visible structures on ul-
trasound. Thus, students practising on patients may inflict serious 
harm. Fortunately, these challenges can potentially be surpassed by 
having students initially train on spine phantoms,9 low-cost simula-
tions where a spinal model is immersed in a solid gel medium. Spine 
phantoms have been shown to possess similar echogenic properties 
as human bodies, and can be constructed to mimic a wide variety of 
patient characteristics (eg. obesity, kyphosis, scoliosis, etc.).
Currently, there is a lack of research to assess the safety and 
cost-effectiveness of ultrasound-guided lumbar neuraxial block-
ade, and few studies to directly compare it against the conventional 
method in terms of patient outcomes. One major reason is that uti-
lization of ultrasound for lumbar neuraxial blockade is adopted by 
only a few practitioners around the world.5 More large-scale ran-
domized clinical trials are required to generate a greater amount 
of rigorous evidence supporting the higher safety of the technique. 
Thus, there are still several hurdles that must be leaped before ul-
trasound-guided lumbar neuraxial blockade can be established as 
the standard of care, and one must be patient. However, the already 
existing demonstration of its higher accuracy combined with the 
relatively low cost of ultrasound scanning makes the situation very 
encouraging.
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International surgery interest in 
Canadian medical training programs
David Mainprize (Meds 2015), Jimmy Yan (Meds 2015), Mike Livingston (Gen Surg PGY 3) 
Globalization is the zeitgeist of our current world. With tech-
nological innovation and commercial liberalization, interactions 
across borders are being propelled forward at a meteoric pace. 
Health care systems have also been increasingly engaged in inter-
national endeavours through advances in medical education, bio-
medical research, and information dissemination. A part of this 
health care globalization process has been the promotion of public 
awareness and prioritization of international public health. Glob-
al health continues to be a growing interest among both medical 
professionals and trainees, and international programs have been 
established or supported in undergraduate and post-graduate med-
ical education in each of Canada’s 17 medical schools.1 
Despite the increasing awareness of international health ac-
tions, not all areas of the global health sphere are equally represent-
ed in this effort. Major global health advances and infrastructure 
have been invested in fields such as infectious disease, epidemiol-
ogy, community health, and occupational health while the field of 
surgery has been relatively underemphasized and referred to as the 
“neglected stepchild of global health.”2 While it has been estimated 
that approximately 11% of the total global burden of disease can be 
attributed to surgically amenable conditions,3 only 3.5% of surgical 
procedures worldwide are carried out in the poorest third of coun-
tries where surgical need is the greatest.4 Even more distressing, an 
estimated 2 to 3 billion people in the world are without access to 
basic surgical care.5,6 While the awareness of global infectious dis-
ease issues has pioneered incredible international efforts resulting 
in substantial global impact on diseases such as polio, smallpox, tu-
berculosis, and AIDS,2 an analogous movement championing inter-
national surgery as a public health initiative to address the immense 
gap between surgical need and provision in impoverished nations 
has been slow to gather momentum. 
Traditionally, the languid push for monetary and political sup-
port towards surgery and perioperative care as a global health pri-
ority has been attributed negative perceptions. Common miscon-
ceptions towards international surgical care include thoughts that 
these efforts are not cost-effective, require too large an initial capital 
investment, require highly specialized training programs, and have a 
disproportionately small impact on the population.7 However, more 
recent research by physicians with interests in global health and 
groups such as the Disease Control Priorities Project have revealed 
that surgical interventions are cost-effective and can provide essen-
tial care to the most vulnerable in impoverished populations.8,9 One 
issue delaying the correction of these misguided perceptions results 
from the minimal exposure to international surgery that medical 
professionals receive in their early training stages.10 As Canadian 
training programs have begun to incorporate focused objectives on 
global health in their curriculum,1 inclusion of international surgical 
health education may reframe its current misconceptions and in-
spire a greater interest on global surgical health.  
 One of the main founders and promoters of international sur-
gery was Canadian surgeon Dr. Norman Bethune who described 
the field as ‘a humanitarian branch of medicine concerned with 
the treatment of bodily injuries or disorders […] including cooper-
ation and understanding between nations involving education, re-
search, development and advocacy.’11 Spearheading the pursuit of 
Dr. Bethune’s vision in Canada is the Committee of International 
Surgery, a branch of the Canadian Association of General Surgeons, 
whose main directive is promoting international surgical aware-
ness and service among Canadian surgeons and residents.13 Several 
studies have been performed to assess the level of awareness and 
interest toward international work in the surgical community. 
 A study in 2003 has shown that interest in international medical 
efforts increased from 6%-20% between 1984 and 2003 in US medi-
cal schools and is thought to be similar in Canadian programs.12 One 
method of promoting interest and awareness while also providing 
a valuable learning opportunity for residents interested in interna-
tional surgery is elective experiences.  The Royal College currently 
allows 3 months of overseas electives during Canadian residency 
training but funding for these electives is variable depending on the 
affiliated program.11 A recent survey shows that 63% of residents 
would be interested in doing an international surgical elective and 
of those whom had already been on one elective, 98% responded 
with a desire to perform another.11 The same questionnaire evalu-
ating long-term interest in international work found that 25% of all 
Canadian general surgical residents and 80% of those who had done 
a previous international elective were interested in incorporating 
international surgery into their careers.11 Similar surveys have been 
performed with surgical staff to assess their interest and support 
for international work. One such survey run by the University of 
Toronto in 2002-2003 indicated that 46% of staff were interested 
in being involved in international work, and of those who had pre-
vious international experience an overwhelming majority found it 
personally and professionally beneficial.11 Approximately ¾ of the 
respondents in this study believed that medical students and resi-
dents should be encouraged to pursue international electives and 
that more funding should be made available to facilitate this goal.11 
 These surveys illustrate the strong interest among Canadian 
surgical residents and staff towards participating in international 
surgery. Efforts to explore the discrepancy between the apparent 
interest and current initiatives have identified specific barriers pre-
venting students from committing to international work. In one 
survey Canadian general surgical residents identified multiple bar-
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riers including family or other commitments, insufficient elective 
time, a lack of sufficient information or opportunity, and financial 
burden, the last of which was the most commonly cited.11 There 
currently appears to be a strong interest toward pursuing interna-
tional surgery in Canadian training programs but there remains a 
gap between this interest and concrete action, which may be due to 
certain personal and institutional barriers. One of the next steps is 
to improve financial and personal supports for students interested 
in international surgery experiences and introduce the fundamen-
tal concepts of international surgery to the medical undergraduate 
curriculum to motivate and inspire student interest early in their 
careers. Through improved organizational infrastructure and ad-
ministrative support, residents and medical students will gain 
greater access to international surgical opportunities. 
The long term goal of improving international surgery expo-
sure during medical education is to eventually address the surgical 
care deficit, as there are many impoverished communities without 
access to basic surgical care. One avenue of addressing the under-
serviced international burden of surgical disease is by targeting un-
dergraduate medical learners. Early exposure to the field through 
formalized teaching and oversea elective experiences will hopeful-
ly recruit a larger number of students to the field of international 
surgery who may become strong advocates and providers of inter-
national surgical care in the future. Additionally, as student inter-
est grows and institutional supports expand, current staff surgeons 
may be encouraged to become involved more heavily in interna-
tional surgical work creating more teaching and surgical care part-
nerships in areas of the world currently underserviced.
 As much of the world’s most vulnerable populations still lack 
access to safe surgical care, a new generation of surgeons interested 
in and passionate about international surgery is needed to bridge 
this gap. Expanding student interest and improvement of institu-
tional supports to advance the ease of access to elective opportu-
nities for residents and medical students in international surgical 
programs may eventually help address the current unmet burden of 
surgical disease in underdeveloped areas.  
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Social media is a broad term describing a collection of online 
and mobile technologies that allow people to create interactive 
communication channels.1 These mediums can be used to create, 
monitor, manipulate, and share a variety of content including text, 
audio, video, or digital images. Its use can be done actively in re-
al-time or passively through different platforms such as individual 
blogs, websites, YouTube, podcasts, social networking sites, or even 
an online discussion forum.2 The user base of these sites has formed 
an evolving digital community known as Web 2.0, or the Social Web, 
the internet’s second version. The crux of Web 2.0 is interactivity, 
content is no longer simply ‘pushed’ to viewers, but a dynamic ex-
change of  ‘push, pull, and create’ by all users.3 Social media serves 
as the defining element of Web 2.0. 
Regardless of how it’s defined, social media has become a prom-
inent discussion point in the medical profession. Survey findings 
report that over half of Canadian physicians use at least one form 
of social media, and over 80% of Canadian physicians expressed 
concerns that social media “poses professional and legal risks to 
physicians.”4 Indeed, in a field where confidentiality and trust are 
paramount, it is easy to see why physicians are hesitant to embrace 
social media and it’s insouciance towards personal privacy in their 
professional lives. Medical students are also wary about their ac-
tions on social media: opting to hide themselves away, limiting their 
privacy settings or even deleting their accounts when CaRMS se-
lection rolls around. 
Yet, consider the following bits of information. The current 
global active user base for Facebook is over 1.1 billion users;5 the 
registered user base of Twitter is over 500 million, with over 340 
million tweets generated daily.6 In comparison to the 38 and 13 
years it took the radio and TV, respectively, to be adopted by 50 mil-
lion users, the times that Facebook (1 year) and Twitter (9 months) 
reported are eye-opening.7 Furthermore, these users are everyday 
individuals, and they are everyday patients. To disregard social me-
dia would be to overlook significant aspects of how patients are get-
ting and communicating information.
Additionally, due to the pervasiveness of Web 2.0 and its abili-
ty for information to be created and stored by any user, simply de-
taching oneself from social platforms or changing privacy settings 
does not guarantee one’s personal activities and online presence 
will remain anonymous or publicly un-cited. Photos or videos of 
medical students or physicians can still be posted by peers or col-
leagues identifying them. Comments, tweets, and mentions that 
include one’s name can also be made by any friend, co-worker, pa-
tient, or even strangers, and once those words are put online, there 
will always be a way for it to be found.2 Patients googling a phy-
sician, hospital, or medical school can, and will find, information 
made by other people. If one rejects participation entirely in these 
social platforms, the ability to mold the online content around them 
is lost. Medical professionals need not become envoys in all aspects 
of social media, but at the very least become knowledgeable of their 
own digital footprints. 
The debate on whether physicians should be engaged on social 
media professionally will continue on, and illustrates why this topic 
needs to be brought into current medical education. Consider the 
following summary of the possible benefits and uses for social me-
dia in medical care: 
benefits of social media use
1. Opening Physician-Patient communication channels
Social media is the gateway for online communication. The in-
teractive exchange along these platforms can strengthen the phy-
sician patient relationship by giving a new means for patients to 
reach medical professionals. It places the patient truly at the centre 
of care as they can communicate their research and ask questions 
on their own schedule, even from the comfort of their own homes. 
Used strategically, social media allows for greater patient participa-
tion and autonomy in their health care. 
2. Improved access to knowledge and resources
One great feature of social media is its ease of customization. 
Professionally designed Facebook pages, YouTube channels, blogs, 
Twitter accounts, and web forums allow users to subscribe to in-
formation on their own topics of interest. These include some of 
the most established medical organizations, including the New En-
gland Journal of Medicine (@NEJM), and the Lancet (@TheLan-
cet). These platforms can all be great tools for self-directed adult 
learners, giving users the freedom to learn within their own sched-
ules and often a variety of modules to accommodate individual 
learning styles.8
3. Public Campaigns
Social media can bring public awareness of healthcare initia-
tives. In spring 2012, Facebook launched a feature that allowed US 
and UK users to share their organ donor status with their network, 
the addition of this tool prompted a huge, albeit transient spike in 
local organ donation registry sign-ups.9,10 This effect was also seen 
in Canada. For example, Ontario’s Trillium Gift of Life registry also 
reported an increased number of individuals signing up following 
the move by Facebook.11 There could be a potential future avenue 
for social media in garnering support to organ donations, blood 
drives, or other public health campaigns.
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4. Physician to physician networking
Indubitably social networking can be a great asset for physi-
cians to reach each other. Social media platforms allow easy shar-
ing of links, articles, research interests, and can generate discussion 
among those with common interests.1,2 For example, The Skeptics 
Guide to Emergency Medicine (theSGEM.com) is a physician cre-
ated and operated website that utilizes Facebook, Twitter, Google+, 
and weekly podcasts to share Emergency Medicine clinical sce-
narios. Since its inception in 2012, it has already been linked with 
other podcast groups with similar goals, and is included in a global 
community of physicians committed to providing free open-Cited 
resources for medical education.12,13,14 Another avenue that social 
media has become useful for physician networking is within con-
ferences. Many medical conferences have adopted official Twitter 
hashtags – labels which allow users to find content related to that 
tag easily. Through Twitter and these hashtags, physicians at con-
ferences can find out, in real time, information from workshops 
they could not attend from those present, engage in side discussion 
about a talk with other listeners without interrupting the speaker, 
and make acquaintances with other physicians there. The ability to 
connect and communicate from any part of the world, as long as 
one knows which hashtag channel to follow, is a powerful advan-
tage which allows physicians to form online global networks.  
5. Monitoring of disease trends
With greater participation of patients in the access of health in-
formation, the data in what is being searched or asked about can be-
come value to survey and monitor as well. The 21st century saw the 
beginnings of a new field of data analysis: infoveillance.15 This is the 
field where health informatics are used to track user queries and 
recognize patterns that are associated with specific disease param-
eters. Closely related to this is the new field of infodemiology: using 
information from an electronic medium, specifically the Internet, 
within a population to shape and inform public health and policy.15 
One of the more well-known examples is Google Flu Trends, which 
keeps tracks of online search queries from a particular population 
region to provide real-time estimations of flu outbreaks within that 
area.16 Information sent over Twitter has also been tracked in order 
to see how it can be used to monitor disease.17 Other research has 
been conducted to see if social media can be used to predict the 
incidence of depression and other mental illness in a population.18
6. Positive professional image
There is a great deal of concern about the content of a phy-
sician’s online life not only damaging their professional image but 
also compromising the reputation and general confidence in the 
medical profession.1,2 While these concerns are fundamentally 
reasonable, physicians and medical trainees can work proactively 
to create a positive online presence. This is achieved through pur-
poseful and curated activity over social media. Adding a stronger 
physician presence can help provide patients with better access to 
doctors, more credible sources for information, and a stronger voice 
to balance the other sorts of opinionated claims online.2,3 
conclusions
Social media has clear potential to greatly enhance the field of 
medicine. However, without early exposure and guidance on prop-
er use, it will remain a hesitant and nebulous subject to approach. 
As current and future patients are becoming more adept at utilising 
social media, likewise medical education needs address this area 
and train students appropriately. It is time to be proactive in the 
handling of social media and train the next generation of physicians 
into the Net generation of physicians. 
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abstract
The field of cancer therapeutics is rapidly evolving. Of particular 
interest is the potential for nanotechnology to overcome one of 
chemotherapy’s biggest barriers: targeted drug delivery. Owing to 
the sheer small size of nanoparticles, the opportunity arises for 
chemotherapy to be administered much more accurately to can-
cer cells while sparing healthy adjacent tissues. In this article, we 
review the various tools in nanotechnology that have emerged as 
candidate delivery systems for chemotherapeutic agents. We dis-
cuss the ways in which nanotechnology has been demonstrated to 
eradicate cancer cells and comment on both successes and current 
limitations.
introduction
Cancer dates back to the time of Hippocrates, who described 
it using words like carcinos, Greek for crab or crayfish. The oldest 
known description of a surgical procedure for cancer was developed 
in Egypt and thought to originate from approximately 1600 BC; the 
papyrus made note of 8 ulcerations of the breast treated via cauter-
ization and concluded that “there is no treatment” for the disease.1
At the turn of the 20th century, William Stewart Halsted, profes-
sor of surgery at Johns Hopkins University, developed the technique 
of radical mastectomy,1 which became the mainstay of breast can-
cer treatment until the mid-1970s, when less disfiguring procedures 
were found to be equally effective and carry less complications.
The evolution of cancer surgery mimics that of both radiation 
therapy and chemotherapy. Radiation therapy began with the dis-
covery of primitive X-rays but today, we have at our fingertips the 
services of computed tomography (CT) and magnetic resonance im-
aging (MRI) to more accurately locate tumours and determine the 
required dose of radiation. Chemotherapy can be traced back to the 
use of mustard gas in chemical warfare during World War II and 
presently, oncologists are equipped with a wide array of chemother-
apeutic drugs including alkylating agents, antimetabolites, and vinca 
alkaloids, to name a few. 
With further development of combinational chemotherapy 
and radiotherapy, the field of cancer therapeutics began to flourish 
at an exponential rate. Nonetheless, the lack of target specificity of 
anticancer agents (ie their relative inability to accurately distinguish 
between normal and cancerous cells) remains a nagging problem in 
the field of cancer medicine.2 The birth of nanotechnology, which 
involves the synthesis of materials and devices to manipulate mat-
ter at an impressively small scale, presents the opportunity for che-
motherapy to be more accurately delivered to target tissues, thereby 
minimizing collateral damage to the surrounding tissues.2 Here, we 
discuss the principles, successes, and limitations of nanotechnology 
as it relates to cancer medicine.
nanotechnology in drug delivery
Various tools in nanotechnology have been explored with re-
spect to their potential roles in cancer medicine; these include lipo-
somes, nanotubes, dendrimers, and many others, each with their own 
unique characteristics. For example, nanotubes, which are carbon 
cylinders composed of benzene rings, can enter the cell via differ-
ent methods, including passive diffusion and endocytosis.3 Further, 
their dynamic chemical properties are conducive to the manipula-
tion of their solubility so that drugs contained within the tubes can 
be released at a specified rate. Alternatively, liposomes, which can 
form lipid bilayers, are able to carry both hydrophilic and hydropho-
bic molecules simultaneously, and are therefore attractive vehicles 
for combinational drug therapy.4 Furthermore, the newest classes 
of dendrimers, characterized by their tree-like branches around an 
inner core3 that provide vast amounts of surface area for drug attach-
ment,5 have been modeled to carry a therapeutic drug, a diagnostic 
agent, and an active targeting molecule all in a single dendrimer.4 Ev-
idently, nanotechnology, involving the synthesis of various nanopar-
ticles of different shapes and behaviours, can open a wide avenue of 
possibilities in terms of achieving targeted drug delivery.
There are several ways in which the use of nanotechnology 
has been demonstrated within the realm of cancer medicine. They 
include (but are not limited to): (1) intracellular chemotherapeu-
tic delivery, (2) photothermal ablation of tumour cells, and (3) gene 
therapy.6-8
Intracellular chemotherapeutic delivery takes advantage of 
angiogenesis. Angiogenesis is one of the hallmarks of cancer that 
involves the formation of new blood vessels through which tumour 
cells cultivate themselves by taking nutrients and oxygen from 
surrounding cells. As a consequence of their rapid, uncontrolled 
growth, angiogenic blood vessels form irregularly and are leakier 
than normal healthy vasculature.5,9 Pores in these vessels range 
from a few hundred nanometers to several microns in diameter, 
while their size reaches only 2 to 6 nm in normal vessels. Since 
nanoparticles are within 10 to 300 nm in diameter, they are the per-
fect size for penetrating tumour cells through their blood vessels 
without considerably entering healthy tissues.9 This Trojan horse 
method presents an attractive means of minimizing damage to sur-
rounding cells. 
Photothermal ablation exploits the fact that normal cells under-
go apoptosis at approximately 46°C while cancer cells typically do so 
at about 42°C.10 Several studies have used gold nanoparticles that are 
tuned to be excited only at certain ranges of light, thereby eliminating 
targeted tumour cells while sparing the neighbouring healthy cells.11 
The use of nanotechnology in gene therapy has the potential 
to overcome limitations of current methods, such as reducing the 
health risks associated with efforts relying on viruses.  In a recent 
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study,12 nanoparticles consisting of a synthetic delivery system (de-
scribed in detail elsewhere) along with small interfering ribonucle-
ic acid (siRNA) were successfully designed to reduce the expression 
of RRM2, an established anticancer target.
successes to date
Currently, there are two notable nanotech reformulations of ex-
isting chemotherapeutics that have been approved by the US Food 
and Drug Administration: (1) Abraxane, an albumin-bound reformu-
lation of paclitaxel, a mitotic inhibitor, and (2) Doxil, a nano-sized 
liposome encapsulating doxorubicin, an anthracycline antibiotic.
Since 2005, Abraxane has been used for the treatment of met-
astatic breast cancer for women who failed to respond to first-line 
treatment for metastatic disease and for whom standard, anthracy-
cline-containing therapy was contraindicated.13 It is an antimicrotu-
bule agent that prevents depolymerisation of microtubules, thereby 
inhibiting their normal dynamic reorganization as required for cel-
lular function.13 Abraxane has been shown to confer fewer toxic side 
effects and greater antitumour activity than its non-nanotech coun-
terpart.13 Furthermore, this reformulation eliminates the require-
ment for premedication in anticipation of hypersensitivity reactions, 
reduces infusion time, and allows for the use of standard infusion 
equipment for its delivery.
Doxil was originally approved for its use in HIV-related Kaposi’s 
sarcoma.14 Its application has now extended to the treatment of ovar-
ian cancer and multiple myeloma. Compared to previous standard 
therapy involving doxorubicin or bleomycin and vincristine, Doxil 
was found to be more effective in the treatment of advanced Kapo-
si’s sarcoma.14 In fact, Doxil confers other significant benefits over 
standard therapy, including better overall quality of life, reduced dis-
figuring quality of indicator lesions, and improved pain control and 
energy.14
current limitations
While nanotechnology has opened up a window of endless and 
exciting possibilities into cancer therapeutics, it has its limitations. 
Perhaps the most significant obstacle yet to be entirely overcome is 
the biosafety issue of nanoparticles. This is primarily due to a host’s 
complex immune response to invading nanoparticles. Further in-
vestigations with respect to the distribution, metabolism, excretion, 
pharmacokinetics, and pharmacodynamics of nanomedicines need 
to be carried out if nanotechnology is to become the mainstay of 
chemotherapy.15 
Issues with regards to costs and environmental safety are also 
important to consider. For instance, both Abraxane and Doxil are 
priced at more than ten times the cost of their non-nanotech coun-
terparts, and while they have been demonstrated to markedly im-
prove quality of life as they are less toxic to healthy tissues, neither 
has been proven to significantly increase survival.9 Additionally, 
although nanoparticles appear to impose no immediate threats to 
human or environmental health, long-term investigations assess-
ing risks due to chronic exposures have yet to be undertaken. Of 
particular concern is the early observation that some nanopar-
ticles seem to persist in the environment for longer than others, 
which underlines the importance of thorough risk assessment and 
management.16 The field of cancer therapeutics will only contin-
ue to expand and evolve, and while nanotechnology could be the 
long-awaited promising breakthrough, we are simply grazing the 
tip of the iceberg of its true therapeutic potential.
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introduction
Recent advances in molecular biology techniques and imag-
ing instruments have opened up the possibility that genetic-based 
screening and imaging might become faster, less expensive, and 
more available.1 One condition where these new technologies could 
have an application is juvenile-onset open-angle glaucoma (JOAG). 
Current practices for detecting cases of juvenile- onset glaucoma 
involve measurements of intraocular pressure (IOP) and optic 
nerve assessment by cup-to-disc ratio (CDR). These practices are 
far from perfect, and results vary from one ophthalmologist to the 
next. Furthermore, because the levels of IOP and the CDR at which 
pathology is likely to be seen have not been well defined there is 
a degree of uncertainty in determining whether or not a diagno-
sis of glaucoma can be made.2 There are problems in the guidelines 
for current screening for JOAG and the solution to these problems 
could lie in new technologies such as genetic screening and imaging 
that could potentially complement each other in helping to better 
screen for this disorder in the future.
background
Glaucoma is a disease of the eye characterized by increased IOP 
and progressive degeneration of the optic nerve leading to perma-
nent visual loss. JOAG has a prevalence of 1% in the population and 
presents in affected individuals between the ages of 3 and 40. Its 
pathophysiology can be traced to defects in genes, like myocilin, that 
code for structural components of the eye.3 JOAG is inherited as an 
autosomal dominant trait and could be detected early in development 
using imaging of the retina and optic disc at high resolution. The dis-
ease is currently detected by measures of IOP. When the increased 
pressure is noted it can be reduced with medications or laser surgical 
procedures,4 though these techniques prevent progression but do not 
reverse damage. While screening for glaucoma is done in adults in 
order to detect increases in pressure and allow initiation of treatment 
prior to optic nerve damage, it is uncommon to employ such practic-
es in children. Still, while it is uncommon for the disorder to present 
at such a young age, in cases of JOAG optic nerve damage can develop 
at a very early age and is irreversible.5 As such, genetic screening and 
imaging in this younger group of individuals could be useful tools for 
identifying JOAG early before damage occurs.
current practice
Currently there are no screening programs for JOAG. The diag-
nosis is made on an individual basis by combining information from 
IOP testing and fundoscopic evaluation of the CDR with additional 
supporting signs such as visual field loss, presence of myopia, and 
blurry vision due to corneal edema or thickening.5 The diagnosis 
can be made earlier in children who have a parent, sibling, or more 
elderly family member affected by the disease. This diagnosis re-
quires clinician judgement, and the interpretation of what is sig-
nificant is subjective and may differ from one ophthalmologist to 
the next. However, an earlier diagnosis results in a more favorable 
outcome because measures to prevent further optic nerve damage 
are taken earlier.6 Criteria for diagnosis were developed from just 
one demographics study of congenital, infantile, and juvenile glau-
coma. Given the lack of research currently being used to establish 
existing diagnostic criteria, and that intraocular pressure gives us 
no indication of the extent of optic nerve damage, there needs to be 
a more reliable method that can be used to both diagnose JOAG and 
assess optic nerve pathology. 
The present treatment for JOAG is trabeculectomy, which usu-
ally results in considerable benefit. However, the treatment may 
result in harm if it is done before the onset of symptoms. Some 
complications that can arise with premature surgery include hy-
phema, subconjunctival hemorrhage, vitreous loss, and tearing of 
the sclera.7 If the disease is detected early and IOP is monitored 
closely and kept in the normal range, optic nerve damage can be 
prevented. Early treatment is important because a great deal of op-
tic nerve damage has occurred by the time the disorder can be clin-
ically identified.8 This risk gives incentive for identifying individu-
als with potential pathology and following them clinically.
new techniques in screening
An emerging tool that may aid in diagnosis of this disorder is 
genetic testing because JOAG exhibits genetic inheritance. Some 
genetic variants exhibit more expressivity than others, and genetic 
testing will allow difficult cases to be more easily recognized and 
treated. Three main gene variants are implicated, all encoding pro-
teins of the trabecular meshwork of the eye. Mutation of the myo-
cilin (MYOC) gene is the most important of the 3 because it is im-
plicated in cases where subjects have an earlier onset of disease, 
high intraocular pressure, and a strong family history.9 Between 
6 and 83% of JOAG cases are associated with MYOC mutations.10 
A strong family history provides an important clue about whether 
or not screening for the disorder is appropriate. Genetic testing in 
such families would result in a better prognosis because affected 
individuals could be identified prior to disease onset. 
Another test to aid in screening for JOAG is confocal scanning 
laser ophthalmoscopy (CLSO). CLSO is a method of examining the 
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eye that uses microscopy to image the retina with a high degree of 
spatial sensitivity. It is helpful for screening for glaucoma and mac-
ular degeneration. It is currently being combined with adaptive op-
tics technology to provide images of the retina with a higher resolu-
tion. Imaging modalities such as CSLO show promise for improving 
the detection of the optic disc and retinal nerve fiber layer chang-
es that can be used as clinical indicators of developing glaucoma. 
Using this technology in combination with clinical judgement and 
other methods in high-risk individuals could aid in the screening 
and diagnosis of glaucoma.6
limitations
Genetic testing may have an application in JOAG though cur-
rently there are limitations to its utility. Genetic testing for JOAG is 
done by gene sequencing for mutations on chromosome 1. It takes 
approximately 12 weeks to receive results and costs $200 per test.8 
The cost of screening can be high, but there is considerable bene-
fit for doing so in individuals with a previous family history. Some 
possible goals for the future could include reduction in the cost of 
genetic screening and characterization of the genetic determinants 
of this illness.
Further research into developing CLSO is also required before 
it can be widely applied. CLSO is currently limited because mea-
surements may be affected by blood vessels seen in the image of the 
eye, along with anatomic variation or other pathologic processes. 
The resolution of the images this technology produces also prevents 
useful quantitative measurements of changes that are occurring in 
the retina and optic disc.6 Finally, an improved understanding of 
how levels of IOP and CDR are associated with pathology needs to 
be better studied. 
conclusions
Optimal management of JOAG is still hindered by our inabil-
ity to make an early diagnosis in many individuals that present 
with the disease before irreversible damage has been done. Genet-
ic screening and CLSO are two methods that show a great deal of 
promise in advancing the management of this condition; howev-
er, neither is currently useful. Goals for the future should include 
further research and development of these techniques, along with 
better-defined clinical values of IOP and CDR that are significant. 
Genetic-based testing and CLSO may hold significant promise in 
the future for an improved management of JOAG. Specifically, ge-
netic testing may allow for the identification of individuals at a high 
risk for JOAG, who could then be monitored with CLSO to avoid 
irreversible vision loss. 
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A growing number of doctors have reported patients arriving at 
their offices with genotyping results or even readouts of their par-
tially sequenced genome.1
The advent of commercial direct-to-consumer (DTC) genet-
ic testing has made such scenarios not uncommon. For only $100, 
companies such 23andMe will send customers a kit to collect their 
saliva from which the company will sequence certain segments of 
the customer’s genetic code (also known as non-targeted genetic 
profiling genotyping). This genotype will be uploaded to the cus-
tomers’ private account on the company’s website, with which they 
will able to see their results and their risks for developing certain 
diseases. It is important to distinguish these types of DTC tests 
from what are known as whole-genome sequencing (WGS) tests. 
WGS tests sequence the entire genome, a feat that can now be ac-
complished in under a week and for under $10 000.2 WGS tests can 
also be DTC; however they are not as common-place due to the high 
cost and the limited knowledge about interpreting whole genome 
sequences. Non-targeted genetic profiling (NGP) tests genotype 
consumers’ genetic information – that is, that they look for single 
nucleotide polymorphisms (SNPs) in certain segments of the ge-
nome that estimate the risk of a certain disease, usually by com-
paring it to other genetic profiles which are linked to case-control 
studies in which the patient’s disease status was determined at the 
time of the study. However, most of these SNPs only predict slight 
increases in disease susceptibility. These SNP-based genotypes are 
known as non-targeted genetic profiling and their clinical utility is 
questionable at best.3
Many health professionals, including family doctors, do not 
feel comfortable dealing with such scenarios. Reasons include a 
lack of exposure to genomics in medical education as well as the 
tremendous difficulties in objectively predicting disease from any 
genomic sequence or genotype.4,5 One report recently referred to 
NGP genetic tests as ‘fortune telling reports.’3,6 Indeed, in the Unit-
ed States a study found that only just over half of specialists in clin-
ical genetics who had seen patients as a result of NGP tests judged 
the test to be clinically useful.1 Part of the problem is the manner 
in which NGP tests are analyzed. For instance, a recent review of 
two prominent NGP tests noted that they did not focus on diseases 
for which high-risk marker predictions were available, and instead 
chose to report on diseases for which genetic markers only added 
a modest increase in risk.7 The clinical importance of such report-
ing is unclear, partly because the genetic markers themselves do not 
account for 100% of the genetic heritability of a disease.7 There is 
also a lack of consensus amongst companies about the markers to 
use for diseases, and two tests from different companies could thus 
give two very different risk estimates for a disease.7 Commissions 
on NGP testing in the UK and US have also found that there were no 
follow-up systems in place to ensure proper interpretation of test 
results by patients and physicians.8
ethics
The ethical issues converge for both forms of DTC testing – 
WGS and NGP. Both forms of testing suffer from an overload of 
information and an impossibility of deciphering the actual risk of 
disease, which in turn cause problems with informed consent. As 
explained above, this means that the clinical validity and utility 
of NGP and commercial WGS tests are questionable at best, and 
thus the use of NGP testing as a screening tool is problematic. All 
screening programmes need to undergo a risk-benefit analysis to 
minimize the potential of unnecessary testing and treatment.9 The 
World Health Organization has an entire list of criteria for effective 
screening programmes, one of which is that the screening test be 
able to detect a clinically relevant disease for which effective treat-
ment is available.10 Furthermore, the ethical principles of nonma-
leficence and beneficence require that health professionals strive to 
minimize harm and promote the well-being of their patients. Inso-
far as NGP and WGS testing lead to unnecessary testing and treat-
ment, health professionals should strive to educate patients about 
the truth of the tests, including both the benefits and pitfalls. Edu-
cation is especially pertinent, since many NGP testing companies 
claim to offer the tests solely for interests’ sake, and yet will report 
on the genetic predisposition to diseases as serious as breast cancer 
or Alzheimer’s Disease.11
The advent of DTC testing also raises questions about social 
justice. Although doctors consciously minimize requests for unnec-
essary tests, individuals getting DTC tests could feasibly pressure 
their doctors into getting the extra tests done to allay those con-
cerns, and thus drain health care resources. Furthermore, the fact 
that the patients can pay for the DTC tests in the first place means 
that they certainly are not poor, which means that affluent people 
who are ordering such tests will use the health care system dispro-
portionately in comparison to those who are less affluent.12
In WGS tests, issues of privacy, obligations and future uses of 
data pose significant questions. For example, there can be unin-
tended research results, such as an association found between race 
and IQ, which the test subjects might have not consented to. This 
calls for regulation and oversight of the obligations that researchers 
owe to the original test subjects.13,14 This specifically and recent-
ly became an issue when the NGP testing company 23andMe uti-
lized consumer genotypic data and surveys to develop and patent 
a method to detect Parkinson’s Disease. The company mentions in 
fine print that they would own all customer genetic data; still, the 
ethics and law
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consumers whose data were used for the study obviously felt the 
need for reimbursement.15,16 Private ownership of genetic informa-
tion also raises the question of whether such data can be bought or 
sold.11
policies/law
Various societies have formulated responses to DTC testing. 
The American Society for Human Genetics says that there should 
be government oversight and regulation of DTC tests, including 
testing the clinical validity of the claims of the tests. The companies 
offering them should be totally transparent and offer all the possi-
ble information in an accessible manner.17 An editorial in the BMJ 
called for an international industry certification of DTC tests,1 with 
the understanding that an Internet-based industry needs global 
regulation. Similarly, other pieces have argued for more oversight, 
regulation and certification of genetic testing labs to ensure the 
quality of commercial genetic testing,11 and to work towards com-
mon standards amongst DTC testing companies.7
Many European countries, such as France, Belgium, Germa-
ny, the Netherlands and Switzerland have adopted legislation cur-
tailing DTC tests and allowing predictive genetic tests only on the 
request of a health professional.18 Each country still has its own 
approach to DTC tests. For instance, the Netherlands has a frame-
work protecting individuals against screening tools that are clini-
cally useless and that may pose a threat to health. Future regulation 
of DTC testing in the Netherlands specifically could be built upon 
such provisions.18 In the United Kingdom, the Human Tissue Act 
criminalizes the analysis of genetic information without consent,18 
which means the policies with which 23andMe was able to utilize 
consumer genotypes would have to be carefully explained to all of 
their customers so as to ensure that the customers were fully con-
senting to their genetic information being collected and analyzed.
Currently, the United States has the Genetic Information 
Nondiscrimination Act, which prohibits employers and insurance 
companies from using genetic information. However, Canada has 
no such laws regarding the use of genetic information by insurance 
companies for underwriting. The Privacy Commissioner of Cana-
da thus requested two papers on the subject, both of which advo-
cated for a ban on using any genetic information in health and life 
insurance policies. This also included monogenic disorders, as the 
papers argued that they were very rare and would have a limited 
financial impact on insurance companies.19
reality check
It is important to ask at this point – are health and specifically 
health information a “consumption good”?11 And what sort of fu-
ture does this predict for the patient-physician relationship? On 
the surface of it, noted philosopher Ivan Illich’s critique of modern 
society becoming increasingly “medicalized” certainly rings true, 
where people increasingly see their life problems as medical prob-
lems. It is also important to add a dose of reality here – genetics is 
not destiny.20
A recent series of articles in the CMAJ deal with the hyper-
bole surrounding personalized genomics. Simply put, just as the 
original Human Genome Project was unable to find exact genetic 
bases for diseases, sequencing individual genomes is unlikely to 
reveal answers easily. The phenomenon of incomplete penetrance, 
in which a genetically inherited condition may not manifest it-
self phenotypically due to environmental factors, highlights how 
non-genetic factors play a significant role in the development of any 
disease process. The environment and the genome also intersect in 
the epigenome, heritable changes to DNA that do not involve base 
pair sequences and can occur due to environmental stresses. This 
of course further complicates the correlation of a genetic mutation 
with a disease.21-25
The crux of the matter is that while sometimes genetic se-
quencing can reveal genetic mutations that are associated with a 
high risk of disease – as in the case of Huntington’s Disease and 
other monogenic, heritable diseases, or even the BRCA1/2 suscep-
tibility genes for breast cancer – at other times they do not. In oth-
er contexts still, as in the case of pharmacogenetics, it can provide 
useful information about a patient’s response to drugs that would 
prevent allergic reactions or aid in drug dosing. Unfortunately, as 
with most things it will take time and experience to fully flesh out 
the ethical and legal ramifications of DTC testing.26 As health pro-
fessionals we will have to keep in mind our duties to our patients’ 
well-being and question the clinical value of advances in genetic 
testing that emerge in the future.
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health promotion
In 2007, Dr. Margaret Chan, the Director General of the World 
Health Organization (WHO), referred to climate change as “the de-
fining issue for public health during this century.”1 In spite of this 
pronouncement, many members of the public, and of the medical 
community, do not fully appreciate the link between anthropogen-
ic greenhouse gas emissions, rising average global surface tempera-
tures, and human health. In a series of in-depth interviews with 22 
residents of Southern Ontario, researchers found that 77% of inter-
viewees believed that climate change would have health impacts.2 
However, the study participants were generally unable to provide de-
tails about the specific health effects of climate change or to put these 
effects in the context of their own community and their own health.
Although the developing world is much more vulnerable to 
the expected health impacts of climate change,3 this article will ex-
amine the health effects anticipated in Canada and other industri-
alized nations. It will also demonstrate that the responsibility for 
addressing these health impacts lies with primary care providers, 
emergency department physicians, and other medical specialists – 
not just with public health officials. Finally, it will describe these 
impacts in the context of how they will affect the most vulnerable 
members of Canadian society.
Perhaps the most obvious health impact of climate change re-
lates to the increased frequency and intensity of heat waves. We 
have already begun to experience this effect of climate change: in 
Toronto, the number of days above 30°C each year nearly doubled 
during the period of 1995-2005 compared to the period of 1961-
1990.4 Due to the urban heat island effect, which is when the abun-
dance of concrete and asphalt in cities traps more heat compared 
to rural areas, heat-related mortality is expected to be greatest in 
urban areas.5,6 Climate change models have projected a fourfold in-
crease in the number of extreme heat warnings in Toronto by the 
2080s, which could lead to a tripling of heat-related deaths.4 Risk 
factors for heat-related mortality include: extremes of age; living 
alone and being socially isolated; pre-existing medical conditions 
like cardiovascular, cerebrovascular, or pulmonary disease; psy-
chiatric illnesses; not having air conditioning; being homeless; and 
working long hours outdoors.5-7 
Climate change is also expected to lead to an increase of air pol-
lution-related morbidity and mortality. Higher temperatures lead 
to increased concentrations of ground-level ozone, which can lead 
to exacerbations of COPD, asthma, and cardiac disease.6,7 There is 
also concern that climate change will increase pollen production 
and the duration of the pollen season. These changes are expected 
to cause increased morbidity associated with allergic rhinitis and 
asthma, especially among children.5,7,8
The prevalence of extreme weather events, including storms 
and floods, is expected to increase with climate change. In fact, it 
has been estimated that there was a 24% increase in the frequency 
of extreme precipitation events in the United States between 1948 
and 2008.9 Health effects of extreme weather events can include: 
drownings; injuries; infectious disease outbreaks from contami-
nated water supplies; and mental illnesses like anxiety and depres-
sion.5-8,10 A longitudinal study of individuals affected by Hurricane 
Andrew, which occurred in the Southern United States in 1992, 
found that 20–30% of adults in the area met criteria for PTSD at 6 
months and at 2 years after the event.6,10
Another major health impact of climate change will be the 
morbidity and mortality associated with changing infectious dis-
ease patterns. There has been an increase in the incidence of West 
Nile Virus infections in humans, from 62 cases in the United States 
when the virus was introduced to North America in 1999, to 1,338 
cases in 2008.6 This trend is expected to continue as climate change 
leads to an earlier onset of spring and an extended amplification 
cycle for the virus. In general, warmer temperatures, increased pre-
cipitation, and elevated humidity are associated with an increased 
incidence of West Nile Virus.8 Similarly, climate change is expected 
to alter the geographic range of Lyme disease and other tick-borne 
diseases, with warmer temperatures allowing for a northward mi-
gration of the tick vector.7,8 Finally, climate change may lead to in-
creased transmission of water- and food-borne illnesses (such as 
Cryptosporidium and Salmonella, respectively), as warmer tem-
peratures allow for pathogen survival and increased precipitation 
facilitates contamination of drinking water supplies.7,8,11 
As demonstrated above, the health impacts of climate change 
are not merely theoretical, nor are they restricted to the develop-
ing world. They include tangible health problems that fall within 
the scope of practice of Canadian physicians. Medical students, 
residents, and physicians should familiarize themselves with the 
changing epidemiology of diseases associated with climate change 
and be prepared to address these health issues in a clinical setting. 
In a recent commentary for Canadian Family Physician, Dr. Alan 
Abelsohn and others outlined the clinical treatment and prevention 
of several health problems associated with climate change.7 Some 
examples include: preventively counseling individuals at high 
risk of heat exhaustion; treating injuries and PTSD after extreme 
weather events; counseling patients with COPD, asthma, or cardiac 
disease to reduce their exposure to air pollutants; diagnosing and 
treating Lyme disease with doxycycline; and participating in the 
surveillance of water- and food-borne diseases.
Another important reason to be concerned about the health 
impacts of climate change relates to the equity dimension of the 
problem: climate change will disproportionately affect the most vul-
nerable members of society. Children will be at an increased risk for 
morbidity associated with heat waves, air pollution, and gastroenteri-
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tis due to water- and food-borne pathogens.8 Elderly individuals will 
be highly susceptible to heat-related mortality and many of the oth-
er health impacts mentioned above due to their existing burden of 
chronic disease.7 Homeless individuals will be highly susceptible to 
heat exhaustion, the effects of extreme weather events, air pollution, 
and mosquito-borne diseases like West Nile Virus, due to their lack of 
shelter and increased amount of time spent outdoors.6 
Canada’s Aboriginal population will perhaps face the greatest 
burden of illness associated with climate change. The traditional 
diet of some Aboriginal communities could be compromised as the 
changing climate alters the populations of animals depended upon 
for subsistence hunting.11 The increased survival of water-borne 
pathogens could contaminate water supplies in more marginal lo-
cations, while food-borne pathogens could threaten traditional di-
ets that include raw meat.11,12 In more remote communities, coastal 
erosion due to rising sea levels, extreme weather events, and chang-
ing ice distribution could lead to community displacement and 
psychological harm.11,12 In addition, all of the health problems dis-
cussed previously with respect to the general population are likely 
to be exacerbated by the poverty, lack of access to health services, 
food insecurity, overcrowded housing, and other social inequalities 
already disproportionally affecting Aboriginal communities.11 
It is evident that anthropogenic climate change will have ad-
verse health impacts on our patients and communities. It will also 
worsen existing health inequalities in our society. As members 
of the medical profession, we have a duty to address these health 
problems when they arise in our clinical practices, while support-
ing public health programs that aim to prevent climate-related ill-
ness from occurring in the first place. 
Scientists and policymakers addressing climate change have 
often called for a two-pronged strategy that includes both mitiga-
tion and adaptation. Much of what has been discussed previously 
would be considered adaptation, as it involves reducing our vulner-
ability to the effects of climate change. While this may seem like the 
natural sphere of action for health care professionals, I would dare 
to argue that we have just as much of a duty to participate in climate 
change mitigation. This would involve being vocal advocates for 
carbon dioxide emission reductions, calling for investment in re-
newable energy infrastructure, and reducing the energy consump-
tion of our clinics and hospitals. Given the profound health impacts 
of climate change, these actions should be considered primary pre-
vention – and that’s just good medical practice.
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interdisciplinary
Optimus Prime, R2D2, and Wall-E, are examples of how we en-
vision future robots. Though it is difficult to distinguish robots from 
other machines, robots can be defined as machines that are capable 
of performing a variety of tasks with a degree of autonomy from hu-
mans. In this article we will focus primarily on service robots: robots 
which perform services for human well-being and are found outside 
of manufacturing operations.1 The innate qualities of robots—their 
tirelessness, physical robustness, and immunity to emotional stress—
may make them a promising addition to healthcare teams. We will 
explore contemporary examples of how service robots are being used 
in healthcare and the potential role of these robots as members of the 
interdisciplinary healthcare team.
The push towards having robots assist future healthcare work-
ers is arguably driven in part by the projected demographics of indus-
trialized countries. A handful of countries such as Germany and Ja-
pan are facing aging populations: It is expected that by the year 2060, 
40% of Japan’s population and 34% of Germany’s population will 
be over 65.2,3 Furthermore by the year 2060 it is estimated that the 
ratio of nurses to patients in Germany will change from 1:9 to 1:17.4 
The need to ease the workload faced by future nurses has fuelled the 
development of robots to principally assist nurses in physically and 
emotionally demanding tasks.4
The robotic nurse assistant (RoNA) prototype designed by Hstar 
technologies was created to eliminate the repeated strain nurses ex-
perience in lifting and transporting patients.5 Although RoNa moves 
on a set of wheels, the upper portion of the robot appears human-
oid, with large bent padded arms that can be used to lift and transfer 
individuals from a bed to a stretcher.5 Boasting the ability to carry 
and transport patients weighing up to three hundred pounds, RoNa 
shows promise to decrease the injuries suffered by nursing staff and 
patients resulting from lifting accidents.5
Service robots may also be assigned repetitive tasks, such as dis-
pensing and distributing medication. In a case study by Beard and 
Smith, the installation of a medication dispensing machine was found 
to reduce the time hospital staff needed to spend in the dispensary and 
significantly reduce dispensing error.6 If robots were able to autono-
mously dispense and distribute medication to patients, it would reduce 
the workload of nursing staff and pharmacists. Having an entirely au-
tomated medication handling system would potentially allow pharma-
cists to focus purely on their roles as consultants and patient educators.
Even more intriguing than the use of service robots as nursing 
aids or medication dispensaries, is their use as patient companions. 
Paro is a companionship robot designed by Intelligent Systems Re-
search Institute that mimics the appearance of a baby harp seal and 
is primarily used in patients with dementia.7 Despite the robot’s light-
hearted appearance, Paro uses sophisticated machinery which allows 
it to sense sight, sound, balance, and touch.7 Paro responds to the touch 
and actions of patients by blinking, moving its tail, and making affec-
tionate noises.8 Though further studies are needed to explore the pos-
sible long term effects of using Paro on the disease process in patients 
with dementia, studies have found that Paro can improve the mood of 
patients and facilitate social interaction.8 Unlike most caretakers, Paro 
has infinite patience, unlimited time to give, and is non-judgmental. 
In addition, companion robots like Paro may prevent caretakers from 
developing compassion fatigue by bringing about positive responses 
in patients that might otherwise seem unreachable.
It should be emphasized that although Paro can elicit genuine 
human emotions from patients—it is by no means a substitute for 
human interaction. Psychologist Sherry Tuckle points out that Paro 
may fulfil a patient’s desire to tell stories and have conversations with 
it, however it cannot reciprocate the care it receives.9 She also notes 
that if a person constantly interacts with robots rather than humans, 
they will become accustomed to the limited range of responses to 
emotions that robots have to offer.9 Ethicist Christopher Calo puts 
Paro’s true designed function quite eloquently writing, “Paro’s pur-
pose is to grease the gears of social interaction.”9
If the capacity of robots increases, they may one day have a fu-
ture role in diagnosis and screening. In the book Complications, 
Atul Gawande described a study by Edenbrandt et al. involving an 
EKG “competition” between a computer and an experienced car-
diologist.10 The computer made 20% more accurate diagnoses of 
myocardial infarction since the machine was less likely to be biased 
by previous diagnoses, or past experiences. With increasing techno-
logical advancements, it is not unrealistic to presume that the robot 
will eventually become a valuable diagnostic tool. At the same time, 
the clinical experiences, and the gestalt, that every seasoned physi-
cian rely on to see the patient beyond numbers and statistics, will be 
invaluable to make the final treatment decisions and work together 
with patients to achieve their treatment goals.
We have already discussed some contemporary examples of 
healthcare service robots and their potential future role as members 
of the interdisciplinary healthcare team. However, if these robots 
eventually become fully-fledged members of the healthcare team, the 
issue of their appearance is certainly significant. Japanese roboticist 
Masahiro Mari proposed a much cited theory, the “uncanny hypoth-
esis,” proposing that our affection for our robots increases the more 
human-like they are. However, our affection soon turns to disgust as 
soon as the robot becomes almost realistic, such as in the case of a 
corpse-like or prosthetic-like robot. Then, as the appearance of the 
robot becomes more human-like, there is a sharp rise in our affection, 
approaching human-to-human empathy levels (Figure 1).11 In short, 
the ideal health care robot in the future would either look like robots, 
or completely life-like to the point that we may mistake them for a 
person on first glance.
Despite the many potential benefits of incorporating robots into 
the healthcare team, there are also several notable limitations and 
Robots in Medicine 
A future member of the healthcare team?
Kyle Pangka (Meds 2016), Yin Hui (Meds 2015), Alexander Yan (MD/PhD 2018) 
Faculty Reviewer: Dr. Amit Bagga MD, FRCPC (Department of Medicine, Division of Nephrology)
UWOMJ 82:2 | Page 30 | Fall 2013
barriers. In the realm of companionship robots, current research 
challenges include programming personality, empathy, interpreta-
tion of patient’s physiological signals, and behaviour adaptation into 
the robot’s social functions. Research into these areas is currently in 
its infancy.12 Moreover, while many studies report positive effects of 
companionship robots in elderly care, the scientific value of the ev-
idence is limited due to low methodological quality.13 It is also im-
portant to note that even if companionship robots are eventually pro-
grammed to display empathy, the depth of the bond between humans 
may be impossible to reach. Additionally, while many people believe 
that technology such as robotics will improve health care quality, 
safety, and efficiency, fewer people stop to consider that they can also 
introduce errors and adverse events. In Patient Safety and Quality: 
An Evidence-Based Handbook for Nurses, the authors recognize 
four common reasons why the benefits of new technology may not 
be realized: “(1) poor technology design that does not adhere to hu-
man factors and ergonomic principles, (2) poor technology interface 
with the patient or environment, (3) inadequate plan for implement-
ing a new technology into practice, and (4) inadequate maintenance 
plan.”14 Certainly, there may be many unforeseen circumstances 
where robots may cause harm to patients. More studies need to be 
conducted with every new application of robotics in medicine. An-
other issue is the potential for robots to cause lost jobs. It is unknown 
whether robots will eventually replace healthcare workers in order 
to lower personnel costs or only function in an assistive capacity.
The strengths of many contemporary healthcare robots, such as 
Paro and RoNa, are geared towards aiding patients with limited mobil-
ity or declining mental function. This seems highly appropriate in the 
face of the aging populations in many developed countries. However, 
we have yet to tap into the capacity for logic that robots can be pro-
grammed to have. In the future, robots may be more actively involved 
in the distribution and dispensing of medication, patient screening, 
and diagnoses. At the same time, advancements in the function and 
appearance of robots should be done in a way that mitigates any initial 
uneasiness that patients may feel while interacting with a robot. From 
the examples cited thus far, robots have proven useful when it comes to 
lessening demands on healthcare staff and increasing the quality of life 
of patients. Robots will likely continue to modify the roles of various 
healthcare professionals within the interdisciplinary healthcare team, 
especially as our interactions with robots become increasingly sophis-
ticated. Eventually, they may become fully-fledged members of the 
healthcare team. Nevertheless, in spite of the enthusiasm surrounding 
robotics in medicine, caution should always be exercised. The benefits 
and potential pitfalls of robotics usage need to be further explored.
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An electronic medical record (EMR) is a digital version of a paper 
chart that contains a patient’s medical information from one practice, 
used by health care providers for patient care.  EMRs have been wide-
ly implemented across the Province of Ontario, with more than 9,000 
physicians and specialists employing such systems in both primary 
and secondary care settings;1 however, problems with intercompati-
bility of various EMR systems as well as legal and funding issues have 
limited the uptake of EMRs.2 Understanding how to further improve 
implementation and efficacy of EMRs across Ontario requires an un-
derstanding of barriers to implementation and the current solutions to 
these barriers, how EMRs are currently implemented and used in both 
in Ontario and across the country, and the current ongoing programs to 
improve implementation and uptake.
EMRs have some benefits to physician practice.3 It has also re-
cently been estimated that EMR systems in primary care centres 
throughout the country have saved the Canadian health care system 
approximately $1.3 billion over the past 3 years.2 EMRs have been 
shown to reduce the number of duplicate tests ordered, benefiting 
not only the patient but the health care system.2 EMRs also reduce 
the number of adverse drug events, thereby improving patient safe-
ty.2 Further, EMRs reduce time spent on administrative tasks, im-
proving efficiency within the physician’s office or hospital,2,3 and 
have also been shown to decrease wait times for patients with ur-
gent concerns to see their family physician.4 EMRs also improve 
both disease management and preventative care.3 In addition to 
these benefits, EMRs can be used to identify patients who are due 
for a screening or preventative visit, or patients who have been 
flagged with abnormal test results and cue to schedule an appoint-
ment.5 Further, EMRs can be used to track blood pressure, weight 
or other health indicators over time, displaying them graphically 
for both the physician and the patient.5
Despite the many benefits of EMR systems, enabling prov-
ince-wide implementation has proven challenging.  Barriers such 
as the time involved for a practice to convert to EMRs from paper 
records, the training of health care professionals on the new sys-
tems, and computer literacy have slowed the implementation of 
EMR systems in many practices.6,7 Other barriers also include the 
financial cost associated with purchasing the new EMR system and 
availability of technical support.7 To encourage physicians across 
the province to use EMRs, the provincial government has intro-
duced programs such as the New EMR Adopter Funding Program 
which provides funding to physicians in the transition from pa-
per-based records to EMRs.8 While this program reduces the finan-
cial burden of switching from paper to electronic records, training 
and computer literacy continue to be a challenge.
In addition to the above barriers, legal concerns have also come 
to light. These issues include who owns the records, who has access 
to the records and how the records can be secured to ensure priva-
cy. Before electronic records, the physician was responsible for ac-
curately documenting every patient encounter, storing the records 
securely and retaining these records for 10 years after the last en-
try.9 With the advent of EMR this has not changed; however, it does 
become more complicated. If one patient sees multiple physicians, 
each will be altering the patient’s EMR.  Who, then, is responsi-
ble for ensuring the record’s accuracy?  The College of Physicians 
and Surgeons of Ontario (CPSO) has clarified this point by stating 
that physicians are accountable for all of their own entries into a 
shared record.9 The CPSO has also set out requirements for ensur-
ing security of EMR.  These include keeping track of all medical and 
non-medical staff who have access to the EMR system, ensuring 
user identification be used to keep track of who has accessed which 
records, controls to restrict access based on user’s role, encrypting 
any data stored on a mobile or external device, and ensuring that 
all wired and wireless connections are secure.9 Requirements for 
retention of records are not stated to be any different with EMR 
as opposed to paper records, except that a physician is required to 
regularly backup their records and store them securely.9
Progress has been made in Canada towards more physicians 
and health care practices using EMRs instead of paper records. 
The Health Council of Canada reports that 57% of primary care 
physicians now use EMR, compared to only 37% in 2009.10 This 
progress, however, is not evenly distributed across the country. 
British Colombia has the highest adoption rate, with over 70% of 
physicians using EMR; New Brunswick, on the other hand, has 
only a 26% adoption rate.10 It was found that an important factor 
in increasing adoption in a province is the provision of technical 
support.10 Support staff allow novice users to move forward and 
overcome the time and computer literacy barriers, thus making the 
implementation process smoother.6,10 Canada Health Infoway is an 
organization created by the Government of Canada to plan a stra-
tegic approach to a Canada-wide electronic health system.2 This 
organization has a number of projects underway to create this na-
tion-wide system, including programs to guide and assist provinces 
and territories in implementing technologically based health care 
systems, programs which improve the intercompatibility of various 
EMR systems and programs which set guidelines and standards 
for emerging technological solutions, all designed to improve EMR 
adoption rates across the country.2
To improve not only implementation of EMRs, but also the ef-
fect of EMRs on patient care and the health care system, the Prov-
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ince of Ontario created the eHealth Ontario program.1 Past spend-
ing and oversight scandals within this program and its predecessor, 
Smart Systems for Health Agency, have slowed the progress of the 
implementation of EMRs within Ontario11 and resulted in some 
public wariness of a province wide Electronic Health Record sys-
tem linking all of the EMRs and other patient health information.12 
eHealth Ontario, however, does currently have a number of initia-
tives designed to improve the uptake of EMRs as well as to improve 
interconnectivity of these records, further increasing efficiency 
within the health care system.1 These include the New Adopter pro-
gram mentioned above, as well as the Regional Integration program, 
designed to increase interconnectivity within South West Ontario, 
Greater Toronto and North East Ontario regions, and the Ontario 
Laboratories Information System, designed to allow physicians to 
access laboratory test results online.1 These programs, along with 
a number of other initiatives, have the potential to improve EMR 
adoption, use and health information connectivity in Ontario.
Research evidence has shown EMR systems have the potential 
not only to decrease health care spending, but also to improve pa-
tient outcomes and workplace efficiency.  While the shown benefits 
are impressive, progress towards a fully electronic province-wide 
system has been slow as a result of a number of identified imple-
mentation challenges including technological, legal and funding 
issues.  eHealth Ontario is working on a provincial level while Can-
ada Health Infoway works on a national level to overcome these 
barriers and produce an efficient and effective electronic health 
care system.  To achieve this, programs which focus on improving 
computer literacy, EMR intercompatibility and financial burdens 
must be a priority.
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profiles
As students sitting in the Office of the Dean, we had every rea-
son to be nervous because in a few minutes, we would have the 
distinct privilege of speaking with Dr Michael Strong. We had tak-
en a break from our daily routine and stepped into Dean Strong’s 
brightly lit office in the Rix Clinical Skills Building. Dr Strong was 
kind enough to sit down with us and share stories about his illus-
trious career, as well as delve into the future of medical education, 
the role of physicians and the Schulich School of Medicine & Den-
tistry.
Dr Michael Strong was born in Windsor and raised in Leam-
ington. He completed 2 years of undergraduate studies in bio-
chemistry at Queen’s University before entering medicine. His re-
lationship with Western University began in 1982 when he began 
an internship in internal medicine and subsequently completed his 
training in neurology in 1987. From there, his career took an inter-
esting turn when he joined the National Institutes of Health for 3 
years doing post-graduate studies. During his time at Fort Detrick 
in Frederick, Maryland he developed the first-ever rabbit model 
for amyotrophic lateral sclerosis (ALS), also know as Lou Gehrig’s 
disease, a degenerative disease of upper and lower motor neurons. 
Dr Strong rejoined Western in 1990 as a clinician-scientist and be-
gan his scientific, clinical and teaching career. He stayed on and 
eventually became chief/co-chair of neurology from 2000 to 2010, 
then dean of Schulich School of Medicine & Dentistry in 2010.  
UWOMJ: What was your path to becoming dean?
Dr Michael Strong: You never start your life off saying you’re 
going to become a dean. It just sort of happens. I started off my 
research career doing experimental neuropathology. The reason 
I went to the lab that I chose was because of the work they had 
been doing on Lou Gehrig’s disease in Guam in the Western Pacific, 
where the incidence was 3000- to 4000-fold higher than what you 
would see anywhere else in the world. To this day, we developed the 
only animal model of reversible ALS. We developed the first tech-
nique that would allow me to isolate the motor neurons, grow them 
in culture and get them to survive. So I became an experimental 
neurobiologist. Ten years later, I was doing a lot of work in protein 
chemistry. We’d isolate the proteins and look at their modifications. 
Ten years after that, we now have found ALS to be an RNA-medi-
ated disorder and are viewed as being the leaders. But if you had 
asked me 20 years ago if I’d be doing RNA biology – [laughs]. Just 
like I would have never believed I would become chief of neurology, 
co-chair of the department or the dean of the medical school. But 
these are just things that happen over your lifetime. 
What is your life like outside of being dean?
I still have my lab – I’m there every Monday morning, Tuesdays 
for grand rounds in clinical neurological sciences and Thursdays 
for journal club. I have three graduate students that I meet with 
every week. And I do a half-day of clinic every Tuesday morning. 
Those pieces of my life continue on. As for hobbies, my wife and 
I love to garden. We love to camp and spend a lot of time camping 
with our kids. And then as we got older we started golfing. We love 
to ski and we do love to travel because there are so many neat places 
to go to in the world. So we try to lead a quasi-normal life.
Where is medical education heading?
There is a difference in what people are looking for in lifestyles 
now. The day of people like myself and some of my predecessors 
working 100 hours per week and trying to drive a lab forward are 
few and far between. I think one of the things we’re going to have 
to be more cautious about is ensuring that people understand what 
balance really means. If you’re going to be a physician you’re going 
to have to look after yourself as much as anybody else. As we move 
forward, we’re going to have to cautiously think about true balance: 
between being an individual, being a physician, having a family and 
our roles in society.
Second, the rate of change in science is phenomenal. Patients 
have the capacity to send off their blood and get their entire genome 
back in weeks. And then they come into your office and say, ‘I’ve got 
a Bcl-1 mutation – what does that mean?’ Physicians need to under-
stand how to get into new literature to better answer those questions, 
but there also needs to be better systems in place in order for physi-
cians and practices to become integrated with emerging science. 
Third, we have decided at this school to do simulations. You al-
ready get tons of it: patient simulations, anatomy simulations – just 
name it we’re doing it. But there’s a difference between doing sim-
ulation because you need to be educated in that realm versus doing 
simulation because you want to be leading in their development. 
I’m never interested in doing something just because you have to. If 
you’re going to do it, do it well enough that you are actually creating 
new knowledge that goes along with that. My medical educators 
are thinking about what is next in the simulation curriculum and 
what resources are required if we’re going to be a leader in it.
What is changing for physicians in the future?
Physicians are the ones that everyone trusts. We get to see the 
impact of a lot of things that are happening in society, so I think we 
have a role and responsibility. At this school, I see everything that 
students do in terms of social responsibility, which is something I’m 
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really proud of. It’s got nothing to do with me, nothing to do with 
Carol Herbert, the previous dean, or anybody before us. It seems to 
be intrinsic to the students. You folks have said ‘this is our respon-
sibility’ – don’t lose it.
What do you think are the future roles of Schulich? 
There are several roles for Schulich locally, nationally and in-
ternationally. Locally, the school must take responsibility in order to 
best serve a population as diverse as that of Southwestern Ontario. 
As a tertiary care center, we serve a population of 6.2 million that has 
everything from absolute rural and underserviced populations and 
First Nations right through to urban populations. Everyone has dif-
ferent health care requirements. So why is health policy established 
somewhere else? It shouldn’t be. I think the school has to take a ma-
jor lead role in being the determinant of health in this region. The In-
terfaculty Program in Public Health will be up and running starting 
in September. It took 18 months from inception; that’s how quickly 
we’re moving and building. It will be the only case-based Masters 
of Public Health program in North America, so we’ll be cutting new 
pathways there. We’re focusing on leadership and social responsibil-
ity and teaching using cases with an international flavour. 
Nationally, there 17 medical schools in Canada and I want to 
have our school clearly identified and recognized as a leader in 
health implementation and social responsibility. On the interna-
tional level, no school can exist in isolation anymore. There is so 
much for us to learn from other areas of the world. It doesn’t matter 
if we’re talking about Africa, China, Saudi Arabia, Budapest or De-
troit. These are areas we’re developing very strong linkages with: 
student exchanges, professor exchanges and curriculum develop-
ment. Over the rest of my term I see our school really developing in 
a meaningful way those types of bidirectional relationships. There’s 
a great amount happening at this school that most people don’t see. 
I’m really changing the focus and direction of this school. 
Do you have one take-home message for those reading this ar-
ticle? 
It’s a great school. There is so much to be proud of. From the 
students through to faculty, the achievements of this school are 
astounding. It’s hard to see when you’re in the middle, but when 
you’re standing outside of it and you get a chance to look, you know. 
I travel the world doing things for this school and people are getting 
to know us. They know our curriculum and what we do in terms of 
research. So for students, you can be proud. There are many things 
that are happening here that have got nothing to do with me. This is 
just the history and the nature of our school.
Introspection and vision are the characteristics that make Dean 
Strong a great leader, evident through the plans he has already set in 
motion but also in the passion he brings to his position. His dedica-
tion to excellence also permeates through his clinical, scientific and 
academic careers. There is no doubt the work Dr Strong is champi-
oning will drive the Schulich School of Medicine & Dentistry for-
ward as a national and international leader in medical education, 
patient care and research. 
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thinking on your feet
Emergency medicine (EM) was born from a public demand for 
a high-quality emergency service that would always be available and 
was meant to serve as a link between out-of-hospital services and 
in-hospital critical care.1 Since the 1950s, hospitals have been the 
preferred locations for around-the-clock diagnostic testing and med-
ical care. Originally, patients went to the emergency department (ED) 
after hours, when they could not access health care anywhere else.1
Today, EDs are notoriously known as places of overcrowding, long 
wait-times and frustrated patients.2 This will continue to be a nation-
al problem. ED crowding leads to delays in care, increased mortality, 
decreased patient satisfaction and physician burn-out. This problem 
is an every-day reality for many EM physicians, reflects a system-wide 
performance issue and can be an indicator of health care quality.3
The causes of ED overcrowding are multifactorial.  Multiple 
strategies have been implemented and evaluated in an effort to im-
prove this situation:  new technologies, triage systems and care-ac-
celerating interventions. In the following section, we have outlined 
and evaluated four strategies to reduce ED overcrowding.
case 1: Hospital & Emergency Ambulance Link (HEAL)4
A 75 year old man with a history of chronic obstructive pul-
monary disease (COPD) lives at home and is on home oxygen. Over 
the past week, his wife has noticed changes in his behavior. After 
breakfast, he complained of nausea, sweating and some shortness 
of breath.  An ambulance was called. On arrival and initial assess-
ment, paramedics suspected CO2 narcosis secondary to the high 
O2 setting on his home oxygen machine.5 En route to the hospital, 
the complete ambulance record was transmitted to the ED using a 
linked computer system.4 The system is comprised of a front-end 
mobile computer to input vitals and interventions, a database serv-
er to send the information and a workstation in the ED to receive 
the information. As the ambulance transported the man through 
the city, the nursing staff was already preparing a room and the 
necessary equipment for his treatment.4
benefits: The advanced data transmission received by the hos-
pital will accelerate patient triage and expedite the delivery of pa-
tient care.  In addition, continuous coverage and advanced warning 
of medical cases will improve bed coordination, overall ED flow 
and may warn of any unforeseen mass casualty.4  
disadvantages: Implementation of the system can be costly, 
particularly in larger centers. Equipment will be required for the 
ambulances and emergency departments and the staff will need to 
be trained in all system operations. In addition, it will take time to 
ensure a coordinated system response by the staff.4
case 2: Fast-track non-acute patient6
A 7-year-old boy is playing outside when he trips, falls and skins 
his right knee. His mother, concerned about infection and unsure of 
his tetanus status, takes him to the ED. Once in the ED, he is triaged 
appropriately to a non-acute setting and does not require an ED bed 
or any urgent interventions. He is taken to a desk-type consulting 
room where he is quickly seen by a physician dedicated to looking 
after the “fast-track” for that day. He is given a tetanus booster and 
swiftly discharged from the ED.  
benefits: Many emergency departments utilize separate streams 
for conditions such as myocardial infarction, fractured femoral neck, 
or critically ill/trauma patients. However, research has shown that 
a separate stream for minor injuries is useful in decreasing waiting 
times and patient complaints.6 Having a nurse practitioner or phy-
sician assistant is often sufficient to deal with minor injuries. More 
efficient evaluation and discharge of ED patients improves ED flow 
and throughput. In addition, this increases bed availability for more 
critically ill patients.6 
disadvantages: A fast track area with chairs and cubicles re-
quires a separate physical space and can be logistically difficult to 
set up.6 
case 3: Rapid Entry and Accelerated Care at Triage (REACT)7
A 27-year-old female who recently moved into the city has been 
encouraged to go to the ED for a flu-like illness. It has progressively 
worsened over the past 2 weeks, but she believes it will improve 
shortly. Her co-worker believes otherwise. She didn’t want to go to 
Hospital A because she’s heard about their very long wait times, so 
she decides to go to Hospital B. 
Hospital B has recently started the REACT program.7 The RE-
ACT program helps to streamline registration of the patient into 
the hospital system with a computerized integrated sign-in, patient 
tracking on arrival and the option for physicians to initiate a range 
of ancillary tests and interventions at triage. During this time ED 
space and beds can be arranged and readied, even prior to complete 
patient registration.7
benefits: The REACT system helps to remove duplicate steps 
in the registration process and allows physicians to start ancillary 
tests prior to assigning patients a bed.7 This will reduce the waiting 
time of patients after they get to a bed, as more results from labs or 
imaging will be available already by the time they are admitted to 
the ED. Physicians will also be able to interview, diagnose and treat 
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a patient faster without having to wait for investigations to return in 
between patient care.  Overall, this strategy has been shown to de-
crease the number of people who leave the ED without being seen.7
disadvantages: This process may require additional staff 
available at triage and in the ED, and may require significant 
changes to the staff culture and processes.  Early laboratory inves-
tigations and imaging tests may increase resource utilization.7   
case 4: Frequent attender intervention8
A disheveled man smelling of alcohol wanders into the ED 
late at night. It is his fifth visit to the ED in the past month.  He 
was concerned because he started feeling “woozy” after a couple 
of drinks tonight. The hospital staff is all familiar with him, and 
no one has very much patience for his antics. The ED has recently 
started a new volunteering program, providing compassionate care 
to selected homeless adults, and one of the volunteers goes over 
and begins talking with this man.8
Over the course of the next hour in the waiting room area, he 
is given a light meal while he talks to the volunteer about his family 
and his life.  He leaves, and doesn’t come back again for the rest of 
the year. 
benefits: Research shows that compassionate care for the 
homeless helps to decrease the subsequent use of emergency ser-
vices and helps decrease repeat visitors.8 While the exact mecha-
nism is uncertain, it is speculated that increasing satisfaction can 
help to reinforce confidence in the medical care received and allow 
patients to wait longer for self-limited symptoms to resolve before 
seeking medical attention. It can also increase trust and lessen pa-
tient concerns.  Reduction in ED visits can decrease the health-
care costs to society.8
disadvantages: Implementation of compassionate care to 
homeless individuals can be difficult as this population is often 
unkempt, may have threatening or aggressive behaviours, and re-
quires much more time to evaluate and treat. It can be hard to train 
and staff volunteers in the ED to be able to provide these services 
and even more difficult to find room in the ED to properly inter-
view and counsel these patients.8
conclusions
Many strategies shown to be effective for improving efficiency 
and throughput in the ED are far from universally applicable and 
not widely adopted. Hospitals need to establish performance in-
dicators for prospective ongoing monitoring of ED overcrowding 
and invest in technology to help track these indicators.3 Address-
ing these issues will help benefit both the physician’s and the pub-
lic’s health – limiting burnout amongst ER doctors while improv-
ing the quality and timeliness of care delivered to patients.9 Given 
that emergency room visits are increasing faster than population 
growth, continued research into and implementation of coping 
mechanisms is vital to providing quality care.10
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